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1 Executive Summary 
Multiple Sclerosis (MS) is a chronic, demyelinating disease which affects 
neurons in the central nervous system. Symptoms of MS include difficulties 
with mobility, gait, bowel and bladder dysfunction, fatigue and cognition. 
People with MS (PwMS) are often diagnosed in their 30s and 40s and up to 
80% become unemployed within 10 years of being diagnosed. This results in 
a negative impact on quality of life. Levels of physical disability do not fully 
account for the impact of the disease on employment outcomes. In fact, 
approximately 45% of people with low levels of physical disability are 
unemployed. It is likely that the impact of “invisible” symptoms of MS, such as 
cognition, can explain this discrepancy. Evidence suggests that cognition is 
also a mediating factor between physical disabilities and unemployment. 
Since unemployment can have a detrimental impact to quality of life, it is 
important to ensure that people with MS remain employed for as long as they 
desire.  
1.1 Systematic Review 
A systematic review was conducted to investigate the link between 
objective reports of cognitive function and unemployment in MS. This question 
was developed using the PICOS tool. The search was carried out in 
September 2017 using three search engines: PubMed, PSYCH Info and Web 
of Science. Identical search terms were used for the three search engines. 
Inclusion criteria were peer review, availability in English, adult participants 
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with a specified age range of 18 to 65 with no neurological conditions prior to 
being diagnosed with MS. Studies needed to include objective 
neuropsychological reports as well as information related to employment 
status, adjustments or accommodations at work or any other negative work 
events. The search returned a total of 910 after duplicates were removed. 819 
were screened by title and abstract, 91 were read in full and 13 studies were 
considered eligible for the qualitative synthesis.  
Four studies included control groups whilst nine included only PwMS. 
Two studies were prospective studies. The 13 studies include a total of 1278 
people with MS, the majority of whom were women (76.10%). 72.10% of 
participants had Relapsing Remitting MS, which is the most prevalent subtype 
of the disease. There was a total of 263 people in the control groups, the 
majority of whom were also women (71.10%). Nine studies were conducted in 
the North American continent, three in Europe and one in South America. 
Quality assessment was carried out using the Effective Public Health Practice 
Tool (EPHPP). Two studies were overall rated as “strong”, eight as 
“moderate” and two as “weak”. No studies were removed as result of their 
quality rating. 
The eligible studies consistently found that PwMS who were unemployed 
or who had more negative work-related events, such as a reduction in work 
hours, performed worse on neuropsychological tests than both employed 
PwMS and healthy control groups. In addition, PwMS who were employed or 
had no changes in their work situation, performed worse than healthy controls 
on neuropsychological tests.  
10 
 
Significant between group differences were seen in a number of 
cognitive domains. These were: processing speed, delayed and immediate 
memory recall and memory and executive function. The most consistent 
difficulties were seen on tasks of processing speed, one of the cognitive 
domains frequently affected by MS given its demyelinating nature. Poor 
processing speeds were significantly associated with poorer work outcomes 
for PwMS. This result was seen on a number of neuropsychological tests.  
Difficulties with delayed recall and short-term memory, both verbal and 
visual, were also associated with difficulties at work or unemployment.  
The relationship between executive function difficulties and adverse 
work events was less consistent than those seen with processing speed, 
short-term memory and delayed recall, but was still present. “Executive 
function” is an umbrella term to describe the cognitive abilities needed to 
successfully carry out goal orientated behaviours which require attention and 
concentration. The three core executive functions are inhibition, working 
memory and cognitive flexibility. Other skills include planning, organisation, 
emotion regulation and problem solving. 
One of the limitations noted by the review was the lack of consistency in 
what was considered employment and unemployment across the studies. As 
well as the difficulties of using a quality review tool largely intended for 
Randomised Control Trials (RCTs) rather than the methodologies required for 
observational, cross sectional studies.  
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1.2 Empirical Study 
Difficulties with executive function in MS have been linked to 
employment and the use of maladaptive coping strategies. Maladaptive 
coping strategies have in turn been linked to increased rates of negative work 
events within the MS population.  
Accurate assessment of executive function is therefore important for 
helping individuals to develop appropriate management strategies at home 
and at work. Whilst there are many well-validated tests of executive function, 
some of these tests lack ecological validity, do not reflect the impact of 
impairment in everyday life and take place in the artificial environment of the 
clinic room. Thus, there is a trade-off between experimental control and 
ecological validity in the assessment of neuropsychological difficulties. 
Assessment in the real world is advantageous but not always feasible due to 
environmental, mobility or risk issues. Immersive and non-immersive virtual 
reality provides a compromise between high levels of ecological validity and 
experimental control. There is also a generally favourable opinion of the use 
of virtual reality in medical settings from the public. 
The Jansari Assessment of Executive Function (JEF©) is a non-
immersive virtual reality test which takes place in an office environment. It has 
been shown to be sensitive to deficits in executive function in people with 
acquired brain injury, and to the effects of drugs with only anecdotal reports of 
executive impairment which have gone undetected by other 
neuropsychological tests. The JEF© has never been used in the MS 
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population. It was hoped that the JEF© would be able to provide results which 
are more reflective of every day difficulties and could be used to improve 
clinical management. This study aimed to compare the sensitivity of the JEF© 
to other executive function tests in MS, as well as determine if the results of 
the JEF© are more closely correlated to coping styles and employment 
outcomes than existing neuropsychological tests. It was hypothesised that the 
JEF© would be sensitive to executive function deficits in this population and 
would be more closely correlated to employment outcomes and coping styles 
than existing neuropsychological tests. 
A total of 18 PwMS and 24 Healthy Controls (HC) took part in this study. 
The MS group was recruited through advertising on MS charity websites and 
social media and from MS Therapy Centres. The HC group was recruited 
through advertising to local community groups and by word of mouth. All 
participants completed the following neuropsychological battery and 
questionnaires: The JEF©, traditional executive function tests (Zoo Maps, Key 
Search and Semantic Fluency), the Brief International Cognitive Assessment 
for Multiple Sclerosis Assessment (BICAMS), the Test of Premorbid Function 
(TOPF), psychological questionnaires (Hospital Anxiety and Depression 
Scale, The COPE inventory and The Fatigue Severity Scale) and employment 
questionnaires (Multiple Sclerosis Work Difficulties Questionnaire and Multiple 
Sclerosis Questionnaire for Job Difficulties).  
The groups were matched in terms of demographics with the exception 
of depression and fatigue. PwMS had significantly poorer scores on the JEF© 
Total Score, JEF© Creative-thinking and JEF© Action-Based Prospective 
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Memory subscales. There were no other significant between group 
differences on neuropsychological tests, with the exception of Zoo Maps. 
There was a significant difference between groups on the employment 
questionnaires, with the MS group reporting more work difficulties. The only 
coping scale which showed a significant between group difference was 
Maladaptive Coping, with the HC group using more of these strategies than 
the MS group. There was a significant negative correlation between the JEF© 
Total Score and the composite score Employment Index and a significant 
positive relationship between the JEF© Total Score and Adaptive Coping 
subscale, as well as between the composite Executive Function Index and 
Adaptive Coping subscale. There was no significant difference in the 
strengths of these correlations. The hypotheses that the JEF© would be 
sensitive to deficits in MS and more closely correlated to employment 
outcomes were supported by these results. These results provide further 
evidence that executive dysfunction is related to negative employment 
outcomes for PwMS and highlights the importance of using ecologically valid 
methods of neuropsychological assessment. They also provide further 
evidence for the use of the JEF© as a tool for the assessment of executive 
function. 
1.3 Integration, Dissemination and Impact 
This thesis has a strong focus on how cognition relates to work 
difficulties in MS. The systematic review demonstrated that there were 
consistent links between domains of cognitive impairment and employment 
difficulties for PwMS. Although the relationship between executive function 
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and employment was less consistent than those seen between other domains 
such as processing speed, it still provided a rationale for the need to do 
further research investigating this relationship. It was noted that only one 
study in the systematic review involved ecologically valid measures of 
executive function. The results of the empirical study were consistent with the 
themes of the systematic review. Namely, that PwMS had poorer scores on 
executive function tests than healthy controls as measured by the JEF© and 
that cognitive difficulties, particularly difficulties with executive function, are 
linked to adverse work events.  
There were several challenges encountered whilst undertaking this work 
which sometimes resulted in limitations. These included changes to the 
neuropsychological test battery in order to prevent fatigue for PwMS, a lack of 
visual acuity and motor function tests, difficulties with obtaining HRA and REC 
ethical approval due to the JEF©’s status as a medical device and lack of CE 
marking, which in turn led to changes to the recruitment strategy. During 
testing, it was noted that the JEF© software itself posed some challenges for 
participants due to the interface through which the individual moves around in 
and interacts with the environment. Suggestions for how to overcome these 
obstacles include having two testing sessions to accommodate a longer test 
battery and the addition of validated tests of visual acuity and motor function. 
Suggestions of how the JEF© software could be improved were made, for 
example adjusting the programming so objects did not disappear as a result 
of human error. 
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Carrying out this study also stimulated much personal reflection about 
the importance of work, the importance of using neuropsychological 
assessment as part of a holistic assessment of work difficulties for PwMS, of 
how I have developed as a researcher and clinician through the DClinPsy 
course and the differences in administering neuropsychological tests within 
clinical and research settings. 
A presentation of the empirical study has been presented to Trainee 
Clinical Psychologists at Royal Holloway. There are plans for the systematic 
review to be published in the Journal of Multiple Sclerosis and Related 
Disorders (MSRAD) and for the empirical report to be published in 
Neuropsychological Rehabilitation. Both these journals are peer reviewed and 
have published articles on similar topics in the past. A summary of the results 
from the empirical article will also be shared with the MS Charities and 
Therapy Centres which provided aid with recruitment, for dissemination online 
or in a newsletter. A longer, discursive article will be co-written with a service 
user, and it is hoped that this article will lead to more awareness and 
understanding of the impact of executive function impairment on employment 
outcomes.  
Dissemination of this work to both service users and professionals may 
result in more awareness of the challenges PwMS face with regards to 
employment, leading to further research in this area as well as the 
consideration of the potential role and impact of cognitive impairment when 
service users report negative work events to their care team. Appropriate 
dissemination may also equip service users and their supporters with stronger 
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arguments for changes to government policy that will support PwMS to stay in 
employment, should they so choose. Finally, it is anticipated that the outcome 
of the empirical study will provide further evidence to the utility of the JEF© as 
an ecologically valid tool for the assessment of executive function, and the 
general necessity of ecologically valid neuropsychological assessments. 
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2 Paper I: The Relationship Between Cognition 
and Employment in Multiple Sclerosis - A 
Systematic Review of the Literature. 
2.1 Abstract 
Multiple Sclerosis (MS) is a chronic, demyelinating disease which affects 
neurons in the central nervous system. Symptoms of MS include difficulties 
with mobility, gait, bowel and bladder dysfunction, fatigue and cognition. 
Approximately 45% of people with low levels of physical disability are 
unemployed. It is likely that the impact of “invisible” symptoms of MS, such as 
cognition, can explain this discrepancy. Evidence suggests that cognition is a 
mediating factor between physical disabilities and unemployment.  
A systematic review was conducted to investigate the link between objective 
reports of cognitive function and unemployment in MS. The search was 
carried out in September 2017 using identical search terms across three 
search engines: PubMed, PSYCH Info and Web of Science. Inclusion criteria 
were peer review, availability in English, adult participants with a specified age 
range of 18 to 65 with no neurological conditions prior to being diagnosed with 
MS, inclusion of objective neuropsychological reports and information related 
to employment.  
The search returned a total of 910 articles after duplicates were removed and 
13 studies were considered eligible for inclusion. The eligible studies 
consistently found that people with MS who were unemployed or who had 
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more negative work-related events, performed worse on neuropsychological 
tests than both employed people with MS and healthy control groups. People 
with MS who were employed or had no changes in their work situation still 
performed worse than healthy controls on neuropsychological tests.  
Significant between group differences were seen in the following cognitive 
domains: processing speed, short-term memory, delayed recall and executive 
function.  
Limitations included the lack of a consistent definition of what was considered 
employment and unemployment across the studies. There were also 
difficulties using a quality review tool largely intended for RCTs rather than the 
methodologies required for observational, cross sectional studies.  
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Table 1 Acronyms of Tests and Batteries used in Systematic Review 
Acronym Name Test(s) battery 
is comprised of 
10/36 
SPART  
Spatial Recall Test  
9HPT  Nine Hole Peg Test  
AI  Ambulation Index  
BADS Behavioural Assessment of the 
Dysexecutive Syndrome 
DEX, Zoo Maps 
BDI  Beck Depression Inventory  
BDI-FS  Beck Depression Inventory – Fast 
Screen 
 
BICAMS  Brief International Cognitive 
Assessment for Multiple Sclerosis 
SMDT (oral), 
CVLT-II, 
BVMT-R 
BNT  Boston Naming Test  
BRB-N  Brief Repeatable Battery of 
Neuropsychological Tests 
SRT, 10/36 
SPART, 
PASAT, WLG, 
SDMT 
BVMT-R  Brief Visuospatial Memory Test 
Revised 
 
CES-D  Centre for Epidemiological Studies 
Depression Scale- German 
 
CMDI  Chicago Multiscale Depression 
Inventory 
 
COWAT / 
COWA  
Controlled Oral Word Association Task  
CVLT-II  California Verbal Learning Test II  
DEX  Dysexecutive Questionnaire (self-
report) 
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DKEFS  Delis-Kaplan Executive Function 
System 
 
DSQ  Disease Steps Questionnaire  
EDSS  Expanded Disability Scale  
EuroQOL  European Quality of Life  
FAMS  Functional Assessment of Multiple 
Sclerosis 
 
FIS  Fatigue Impact Scale  
FSS  Fatigue Severity Scale  
HADS  Hospital Anxiety and Depression Scale  
HrQoL  Health Related Quality of Life  
JOLO  Judgement of Line Orientation Task  
KKG  Fragebogen zur Erhebung von 
Kontrollüberzeugungen zu Krankheit 
und Gesundheit (German 
Questionnaire of Health Locus of 
Control) 
 
LOT  Line of Orientation Test  
MACFIMS  Minimal Assessment of Cognitive 
Function in Multiple Sclerosis 
SDMT (oral), 
PASAT, BVTM-
R, Open Trial 
SRT, COWAT, 
JOLO 
MFIS  Modified Fatigue Impact Scale  
MSFC  Multiple Sclerosis Functional 
Composite 
9HPT, T25FW, 
PASAT 
MSNQ  Multiple Sclerosis Neuropsychological 
Questionnaire 
 
NART  National Adult Reading Test  
NEO-FFI  NEO Five Factor Inventory  
PAM  Patient Activation Measure  
PASAT  Paced Auditory Serial Addition Test  
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PDDS  Patient Derived Disease Steps  
PHQ-9  Patient Health Questionnaire  
RCFT 
(copy) 
Rey Complex Figure Test (copy)  
SET Modified Six Elements Test  
SILS  Shipley Institute of Living Scale  
SRT  Selective Reminding Test  
STAI  State Trait Anxiety Inventory  
SDMT (oral) Symbol Digit Modalities Test – oral 
version 
 
STM  Brown Peterson Short Term Memory 
Test 
 
T25FW  Timed 25 Foot Walk  
TMT  Trail Making Test  
TPQ  Tridimensional Personality 
Questionnaire 
 
USE-MS  Unidimensional Self-Efficacy Scale for 
Multiple Sclerosis 
 
WAIS-R  Wechsler Adult Intelligence Scale 
Revised 
 
WASI  Wechsler Abbreviated Scale of 
Intelligence 
 
WCST  Wisconsin Card Sorting Test  
WLG  Word List Generation Test  
 
 
2.2 Multiple Sclerosis 
Multiple Sclerosis (MS) is a chronic neurodegenerative disease of the 
Central Nervous System (CNS) which is characterised by inflammation, 
demyelination of neurons and formation of plaques at multiple sites 
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(Kutzelnigg & Lassmann, 2014; Milo & Miller, 2014; Nylander & Hafler, 2012; 
Polman et al., 2011). This demyelination and plaque formation disrupts the 
flow of action potentials along the neuron (Kolb & Whishaw, 2008). It is 
estimated that 2.3 million people worldwide are affected by MS and it is one of 
the leading causes of disability in young people of working age. It is also 
associated with a reduced life span in comparison to the general population 
(Bishop & Rumrill, 2015; Lunde, Assmus, Kjell-Morten, Bø, & Grytten, 2017; 
Wicks, Ward, Stroud, Tennant, & Ford, 2016).  
The causes of MS are currently unknown, however research suggests 
that an interplay between genetics, epigenetics and the environment resulting 
in an autoimmune response within the CNS is responsible (Milo & Kahana, 
2010; Nylander & Hafler, 2012; Thompson, Baranzini, Geurts, Hemmer, & 
Ciccarelli, 2018).  
Lifestyle and environmental factors which may contribute to the 
development of the disease include smoking, obesity and vitamin D levels, 
with smoking being a chief contributor (Thompson et al., 2018). There is also 
evidence that there is a relationship between contracting and not contracting 
certain diseases and MS. For example, the hygiene hypothesis proposes that 
becoming infected with several infectious diseases in early childhood can 
decrease the likelihood of developing autoimmune diseases such as MS. On 
the other hand, becoming infected with diseases in early adulthood, such as 
the Epstein-Barr Virus, increases the risk of the individual going on to develop 
MS (Bishop & Rumrill, 2015; Thompson et al., 2018). 
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Heritability of the disease within families, which increases with the 
degree of relatedness, suggests a role for genetics. There is also a pattern in 
the geographic spread of the disease, with people living in northern areas of 
the world more likely to develop the disease. The disease is also more 
common in women than in men and in people of Caucasian ancestry rather 
than people of African, Asian or Hispanic descent (Bishop & Rumrill, 2015). 
 
2.3 Subtypes of Multiple Sclerosis 
Although MS has a heterogenous presentation, it can be separated into 
three main subtypes: Relapsing Remitting MS, Primary Progressive MS, 
Secondary Progressive MS. 
MS often presents with the Clinically Isolated Syndrome, a demyelinating 
event which presages MS, frequently associated with damage to the optic 
nerve, brainstem or spinal cord. However, the symptoms caused by this 
damage often resolve and it is not until the second clinical relapse or MRI 
event that MS is formally diagnosed (Thompson et al., 2018). 
Relapsing Remitting MS (RRMS) is the most common form of MS and 
affects about 85-90% of the MS population. It is characterised by at least two 
relapses which are associated with periods of recovery where the individual 
may reach, or just fall short of, their previous level of functioning. This type of 
MS is seen more frequently in women than in men (Iwanowski & Losy, 2015; 
Thompson et al., 2018). Approximately 40% of people with RRMS will go on 
to develop SPMS within 10 years of being diagnosed. SPMS is a progressive 
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form of the of the disease that may or may not involve relapses. 
Approximately 10% of people with MS (PwMS) will develop PPMS, which is a 
progressive form of the disease from its onset (Thompson et al., 2018) 
. 
2.4 Symptoms and Treatment 
The symptoms and course of MS differ from person to person, however 
they involve difficulties with mobility and coordination of movement, bowel and 
bladder problems, visual disturbances, fatigue, neuropathic pain and cognitive 
dysfunction (Milo & Miller, 2014).  
MS is a degenerative disease and there is currently no cure. 
Consequently, the aim of treatment is to speed recovery from relapses and to 
slow the progression of the disease so that patients can continue to engage in 
meaningful activities and maintain quality of life (Bishop & Rumrill, 2015). 
Treatment of MS may differ depending on whether the disease course is 
progressive or relapsing, suggesting the two subtypes have different 
pathogenic origins, and whether the disease activity is present or absent. 
Steroids and disease modifying, anti-inflammatory drugs with 
immunosuppressant characteristics that target specific cells or proteins are 
used to treat relapsing MS (Comi, Radaelli, & Soelberg Sorensen, 2017; 
National Institute for Health and Care Excellence, 2014). Disease modifying 
drugs are aimed at the most common type of MS - RRMS - and there remains 
a lack of treatments for the other subtypes (Thompson et al., 2018). In 
addition to pharmacological interventions, PwMS may benefit from 
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physiotherapy, occupational therapy and psychological input to help manage 
symptoms and associated comorbidities (Thompson et al., 2018).  
 
2.5 Employment in Multiple Sclerosis 
Approximately half of all PwMS are unemployed which has a major 
negative impact on their quality of life (Kobelt, Thompson, Berg, Gannedahl, & 
Eriksson, 2017). Although two thirds of PwMS are working at the time of their 
diagnosis, up to 80% of people become unemployed within 10 years of their 
diagnosis (Bishop & Rumrill, 2015).  
Employment in MS is related to a higher quality of life. In addition to 
financial benefits, employment also provides an opportunity for social 
interaction, support, and is often related to a sense of identity. PwMS who are 
employed report greater engagement in life activities, community participation, 
adequate social support and better life satisfaction. They also report better 
perceived health and that daily activities, such as walking, are less difficult. 
Comorbidities linked to unemployment in this population include depression, 
loneliness, and anxiety (Balto, Pilutti, & Motl, 2018; Dorstyn, Roberts, Murphy, 
& Haub, 2017). 
Therefore, it is important to understand the factors related to 
unemployment in order to help PwMS to remain at work and maintain their 
quality of life and wellbeing (Bishop & Rumrill, 2015; Wicks et al., 2016). 
 
26 
 
2.6 Reasons for unemployment in Multiple Sclerosis 
Unemployment in this population is related to demographic and disease 
related variables. For example, PwMS who are older and have few years of 
education are more likely to be unemployed, and the link between 
unemployment and physical disability in MS has been widely reported 
(Kavaliunas et al., 2015). In addition, unemployment is also related to 
increased difficulties with mobility, a progressive disease course and length of 
time since diagnosis.  
Despite the many physical difficulties associated with the disease, 82% 
of PwMS are employed at a score of 0 on the Expanded Disability Status 
Scale (EDSS) (indicating no disability). This drops to 55% with an EDSS 
score of 3 or below (indicating only mild physical impairment), but barely 25% 
of PwMS are employed at EDSS 6.5 (moderate physical impairment) (Kobelt 
et al., 2017; Milo & Miller, 2014; Wicks et al., 2016). It seems unlikely that 
physical disability alone can explain these figures, however the “invisible” 
symptoms of MS, such as fatigue, mood and cognition, are possible 
explanations for this outcome (Cadden & Arnett, 2015). 
Research has shown that cognitive impairment is a mediating factor in 
the relationship between disability and unemployment for PwMS (Campbell, 
Rashid, Cercignani, & Langdon, 2016; Deluca, Yates, Beale, & Morrow, 
2015). PwMS who have cognitive impairment are more likely to be 
unemployed (Grech et al., 2017a). Cognitive impairment can be seen in all 
subtypes and stages of the disease and affects 40%-70% of PwMS (Deluca et 
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al., 2015). Furthermore, cognition has been shown to have an impact on 
income which is independent of physical disability (Kavaliunas et al., 2017). 
Cognitive test scores have been shown to separately and significantly 
benchmark groups of healthy employed people, PwMS working competently, 
PwMS working with difficulty and PwMS who are unemployed (Benedict et al., 
2016). 
Given the relationship between employment and cognition, it would be 
beneficial for clinicians to have a good understanding of which cognitive 
abilities are related to negative work place outcomes. This could be used to 
further inform management of the disease and improve work place 
adaptations to help people stay in work should they so choose. 
The aim of this systematic review is to provide a comprehensive 
synthesis of the existing literature investigating the relationship between 
cognition and employment outcomes for working age PwMS. To the best of 
our knowledge this is the first systematic review looking at the relationship 
between, and impact of, cognitive impairment on employment outcomes. 
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3 Methods 
The PRISMA recommendations for reporting systematic reviews were 
used for this systematic review (Liberati et al., 2009). A protocol for this review 
has not been published or registered in a database. The question for this 
review was developed using the PICOS tool (Methley, Campbell, Chew-
Graham, McNally, & Cheraghi-Sohi, 2014).   
 
3.1 Search Strategy and Selection Criteria 
Electronic databases (PSYCH Info, Web of Science and PubMed) were 
searched in September 2017. Uniform search terms were used which can be 
found in Table 2. Duplicate studies were removed before screening by 
abstract and title. Following this, studies were read in full to determine if they 
met the inclusion criteria for this systematic review. 
 
Table 2 Search Terms used for Systematic Review 
Search terms 
Multiple Sclerosis OR relapsing-remitting Multiple Sclerosis OR primary-
progressive Multiple Sclerosis OR secondary-progressive Multiple Sclerosis 
OR primary-progressive MS OR secondary-progressive MS OR demyelinating 
disease 
AND Cognition OR cognit* OR memory OR attention OR concentration OR 
inattention OR cognitive defici* OR cognitive impair* OR prospective memory 
AND Employment OR work OR job OR occupation OR career OR workplace 
OR work-place OR unemployment 
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3.2 Inclusion and Exclusion Criteria 
Studies were included in this review if they were peer reviewed, 
available in English, quantitative and included adults with any clinical subtype 
of Multiple Sclerosis aged between 18 and 65. This age range was used as it 
reflects the ages of the majority of people within the work force. Studies were 
only included if they specified the age range of their participants. This was to 
avoid including studies which had a mean age within employment age, but 
individual participants whose age fell outside of the range. Participants 
included in the study needed to have no other neurological conditions prior to 
being diagnosed with MS as this may have affected their performance on 
neuropsychological tests. Studies needed to include objective information 
about cognitive abilities obtained using standardised, neuropsychological 
assessments. There is evidence that subjective reports of cognition in MS can 
be confounded by mood as well as fatigue, and that PwMS can over- or 
under-estimate their cognitive abilities. (Van der Hiele, Spliethoff-Kamminga, 
Ruimschotel, & Middelkoop, 2012). Studies needed to provide information 
related to the employment status of the participant. This could include: 
employment status, adjustments made at work or any adverse work events 
which had occurred due to MS. 
Participants could be recruited from both community and hospital 
settings and there was no restriction on publication date.  
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3.3 Data Extraction 
Studies were initially screened by reading the title and then the abstract. 
Following this, studies were read in full to determine if they met the inclusion 
and exclusion criteria. Data from the eligible papers were extracted and put in 
to a table. Extracted information included: study design, study setting, 
participant information such as type of MS, how the researchers had defined 
employment and what terms they used, the battery of neuropsychological 
tests administered, any other questionnaires administered and outcomes. 
 
3.4 Quality Assessment 
Quality Assessment was carried out using the Effective Public Health 
Practice Project tool for quantitative studies (EPHPP) (Thomas, Ciliska, 
Dobbins, & Micucci, 2004). This was carried out by the author and verified by 
her supervisor (DL). 
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4 Results 
4.1 Overview 
A total of 1237 studies were found through the literature search. 327 of 
these were duplicates and were removed prior to screening, leaving a total of 
910. After the initial screening by title and abstract, 819 studies were 
removed. 91 studies were read in full and 13 were deemed suitable for this 
review. Four studies included control groups, whilst the remaining nine 
recruited PwMS only. Two studies were prospective studies. See figure 1 for 
Prisma diagram. 
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Figure 1: PRISMA Flow Diagram 
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4.2 Data extraction. 
The search yielded 13 studies which were suitable for inclusion in this 
review. Relevant data from the 13 studies identified was extracted and is 
summarised in Table 3. Please see Table 1 for a list of abbreviations for the 
neuropsychological and psychological measures. 
 
4.2.1 Summaries of Studies Found. 
4.2.1.1 BICAMS in the Argentine population: relationship with 
clinical and sociodemographic variables. 
 
The study by Vanotti and colleagues was carried out in Argentina. Its 
aim was to investigate the relationship between clinical variables of MS, such 
as fatigue, disease and physical disability, and the BICAMS (Vanotti et al., 
2017). The study also analysed the relationship between the BICAMS and 
people’s perception of cognitive dysfunction and other employment variables. 
50 participants were recruited from MS clinics and excluded if they did 
not have a clinical definite presentation of MS, were not fluent in Spanish and 
had any psychological or motor difficulties that would affect interaction with 
the test materials (other than MS). In addition to the BICAMS, participants and 
an informant completed the MSNQ-Patient and MSNQ-Informant 
questionnaires about perceived cognitive function. The EDSS and the MSFC 
were also completed to provide information about neurological disability. Self-
report questionnaires were used to provide information on mood and fatigue. 
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Participants also provided information about their employment status and 
work hours. Employment was dichotomised into “employed” and “unemployed 
specifically due to disability”.  
Analysis showed that the variables with the strongest association to 
BICAMS scores were the EDSS and MSFC, which measure neurological 
disability and function respectively, and employment status. There were also 
significant associations between BICAMS performance and mood, work hours 
and fatigue. In terms of individual subtests, employment status was a 
significant predictor of CVLT-I performance and had moderate associations 
with SDMT performance. 
 
4.2.1.2 Benchmarks of meaningful impairment on the MSFC and 
BICAMS. 
Research conducted by Benedict’s group in America aimed to identify 
meaningful benchmarks of impairment on the components of the MSFC and 
the BICAMS, recognising that clinical interpretation associated with the scale 
scores did not always reflect the individual functional ability (Benedict et al., 
2016). Degrees of workplace failure were used as measures of functional 
impairment. A retrospective analysis of data was carried out for 275 PwMS 
and 114 Healthy Controls, who were recruited through advertising. 
Participants were required to complete the BICAMS, the PASAT (which 
forms part of the MSFC), the T25FW and the NHPT. Information was 
gathered regarding a range of negative work events following mistakes at 
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work in the preceding 30 months, including verbal criticism from superiors and 
formal disciplinary action. Any patient reporting two or more negative work 
events was considered to be at risk of losing their job. PwMS were assigned 
to three groups based on their work experience. Work-stable: full time 
employment, no disability benefits and no negative work events. Work-
challenged: full time employment with two or more negative work events. 
Work-disabled: unemployed and receiving disability benefits. 
 All the motor and cognitive tests were able to discriminate between the 
vocational benchmarks created, with the SDMT and the T25FW being the 
most discriminating. 
 
4.2.1.3 Cognitive impairment among patients with multiple 
sclerosis: associations with employment and quality of 
life. 
 
A study carried out in the UK by Campbell and colleagues also 
investigated the utility of the BICAMS in outpatient clinics and considered how 
cognitive impairment in MS is related to physical disability, employment and 
quality of life (Campbell et al., 2016).  
49 PwMS were recruited from an NHS outpatient clinic, all of whom 
completed the BICAMS, two questionnaires related to quality of life – 
EuroQOL and a generic quality of life questionnaire, a questionnaire 
measuring fatigue, a generic measure for chronic illness management, the 
unidimensional self-efficacy scale for Multiple Sclerosis (a measure of patient 
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empowerment in MS), the HADS, the MSNQ (patient-report) and the FSS. 
Cognitive impairment was defined as performance below the fifth percentile 
after accounting for age, sex and level of education.  
Results found that PwMS who were unemployed were significantly more 
likely to show cognitive impairment on at least one test. The SDMT was the 
most significant predictor of unemployment, with poorer performance being 
linked to unemployment. Higher levels of quality of life were associated with 
higher scores on the SDMT and the MSNQ. The study concluded that the 
BICAMS is an easy to administer battery suitable for use in British outpatient 
settings. 
 
4.2.1.4 Brief International Cognitive Assessment for Multiple 
Sclerosis (BICAMS): Canadian contribution to the 
international validation project. 
 
The Canadian validation study of the BICAMS was also considered 
eligible for this study (Walker et al., 2016). The aims of this study were to 
establish whether the BICAMS could be used as a tool in a Canadian clinic, to 
contribute to the international validation of the BICAMS and to investigate 
whether the BICAMS is related to employment status and subjective 
measurements of cognition.  
The study involved 57 PWMS as well as 51 healthy controls (HC) 
matched for age, sex and education. Participants completed the BICAMS, the 
MSNQ (informant and self-report versions), the PHQ-9 (to assess depression) 
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and the MFIS (to assess fatigue). Participants were asked to return for a 
follow up one to three weeks later to assess the reliability of the battery. 
Participants completed alternate versions of the BICAMS subtests to prevent 
practice effects.  
The study found that the BICAMS was able to identify impairment in 
57.9% of their sample, with impairment being defined as “one or more 
abnormal tests”. This is similar to the statistics reported in the literature. The 
SDMT had the most robust findings out of the BICAMS subtests with regards 
to test-retest reliability. Only the SDMT and BVMT-R were able to discriminate 
between healthy controls and PwMS after taking depression and fatigue into 
account. Logistic regression was used to determine if the BICAMS was a 
predictor of employment status and found that the only predictor was the 
BVMT-R which is in contrast to other studies which have found that SDMT is 
a stronger predictor of vocational status. The study concluded that the 
BICAMS would be a suitable measure to use in clinics and showed good 
ecological validity through its relationship to employment status and ability to 
identify impairment. 
 
4.2.1.5 Disclosure of disease status among employed multiple 
sclerosis patients: association with negative work events 
and accommodations. 
 
An American study by Frndak’s group investigated the relationship 
between measures of clinical outcome, (in particular psychiatric and cognitive 
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symptoms), and disclosure of MS to employers (Frndak et al., 2015). It also 
aimed to investigate whether disclosure was related to negative work 
experiences as seen in other populations.  
This study used both a longitudinal and cross-sectional design: 143 
PwMS in the cross-sectional sample and 103 PwMS in the longitudinal 
sample, with 47 participants being in both groups. The cross-sectional group 
were subject to a clinical exam which included a battery of neuropsychological 
tests. They also completed the DSQ and provided information about general 
demographic details, their experience of using accommodations at work and 
any negative work events. The neuropsychological tests were: the BVMT-R, 
CVLT-II, SDMT, and the PASAT. Participants also completed the T25FW, 
NHPT and the BDI-FS. EDSS scores were calculated by a neurologist for 103 
participants. The longitudinal group completed this clinical assessment four 
times. Six people in the longitudinal group disclosed the MS status during the 
study and were used as case examples of disclosure.  
There was no difference in disease course or neuropsychological tests 
scores between the group who had disclosed their status to their employers 
and group who had not. However, there was a difference between groups on 
their T25FW scores, EDSS scores and the DSQ, with the disclosure group 
having significantly poorer outcomes on these measures.  People who chose 
to disclose also experienced more negative work events, had more 
accommodations at work and worked longer hours. 
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4.2.1.6 Factors that moderate activity limitation and participation 
restriction in people with multiple sclerosis. 
 
Goverover and colleagues’ study (Goverover, Strober, Chiaravalloti, & 
DeLuca, 2015) looked into the relationship between cognitive ability, activity 
and participation for PwMS in America. Employment and breakfast 
preparation were used as proxies for activity and participation respectively.  
72 employed and unemployed PwMS took part and were asked to 
complete the MACIFIMS, depression, anxiety and fatigue measures as well 
as rate their cooking abilities. Participants were separated into four functional 
groups: people who were employed and cooked, people who were 
unemployed and cooked people who were employed but did not cook and 
people who were unemployed and also did not cook.  
Unemployment was correlated to increased levels of fatigue and poorer 
performance on the SDMT and BVMT-R from the MACIFIMS. On the other 
hand, cooking ability was positively correlated with processing speed, verbal 
and working memory. 
 
4.2.1.7 Identifying employed multiple sclerosis patients at-risk for 
job loss: when do negative work events pose a threat? 
 
Kordovski’s group aimed to compare the frequency of work difficulties 
and accommodations between PwMS and healthy controls who were 
otherwise matched on demographic variables (Kordovski et al., 2015). Since 
40 
 
they predicted that there would be differences in disease variables and 
employment status between the groups, a second aim was to develop 
normative expectations for these variables to guide clinical management.  
The study was set in New York, America with 138 PwMS and 61 HCs 
taking part. All participants reported being employed and working at least 30 
hours a week. Participants completed an online survey which took information 
regarding disease characteristics, demographics details, MSNQ (informant), 
employment information, including negative work events and job 
accommodations, and the PDDS. Objective cognitive tests included the 
SDMT, PASAT, CVLT-II and BVMT-R. The T25FW and NHPT were 
completed to assess motor function. The BDI-FS was administered to assess 
depression. 
HCs out performed PwMS on the following measures: T25FW, BVMT-R, 
CVLT-II total learning and SDMT. 33% of PwMS would have been considered 
cognitively impaired. PwMS were more likely to report job difficulties and need 
accommodations at work. Work-challenged PwMS (reporting at least one 
negative event) performed poorer than their work-stable counterparts on the 
T25FW, NHPT, PASAT and BVMT-R. Whilst work-challenged PwMS needed 
significantly more cognitive accommodations than work-stable PwMS, there 
was no difference in the number of cognitive accommodations used by 
controls and PwMS in general. 
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4.2.1.8 Work participation and executive abilities in patients with 
relapsing-remitting multiple sclerosis. 
 
Van der Hiele and colleagues (Van der Hiele et al., 2015) specifically 
investigated the relationship between executive function and employment for 
people with RRMS in the Netherlands. Appropriate data was taken from a 
previous study on cognition and MS in the Netherlands. Data from 55 PwMS 
were considered suitable for inclusion for this research. Two groups were 
created based on employment status: employed and unemployed. Both 
groups completed the DEX, a subjective assessment of executive dysfunction 
from the BADS, as well as the NART, TMT, SCWT, WCST, RCFT (copy) and 
the BADS. 
Participants also provided self-reported information on anxiety, 
depression and fatigue using the HADS and FSS. 60% of unemployed PwMS 
reported difficulties with planning and organisation, however this was not seen 
on the overall DEX score. There was a significant difference between self-
reported sustained attention, with the unemployed group reporting more 
difficulties than the employed group. The only executive function test that was 
significantly different between the groups was on WCST category completion. 
Overall, there were below average scores in a cognitive domain in 2-55% of 
participants. The highest percentage of below average scores was seen on 
the RCFT copy and the PASAT.   
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4.2.1.9 Employment status in multiple sclerosis: impact of 
disease-specific and non-disease-specific factors. 
 
Krause and colleagues (Krause, Kern, Horntrich, & Ziemssen, 2013) 
conducted a study in Germany to investigate the disease and non-disease 
related factors which impacted employment status for PwMS in comparison to 
healthy controls. This included looking at the role of health locus of control for 
people with MS. 
87 PwMS were recruited from a health centre and 37 age and sex 
matched healthy controls were recruited through local advertising. The MS 
group was further subdivided into PwMS who had taken early retirement and 
PwMS who had remained in employment. PwMS were asked to complete the 
MSFC and a neurologist rated their disability on the EDSS. All participants 
completed the BRB-N, which tests long term memory, attention and 
information processing speed and executive function. Participants also 
completed measures of depression, fatigue, health related quality of life and 
health locus of control. A measure of fatigue was completed by the MS group 
only.  
The early retirement MS group were significantly older and had fewer 
years of education in comparison to the employed MS group. Rates of the 
progressive subtypes of MS (SPMS and PRMS) were also higher in the early 
retirement group. The early retirement group also had higher levels of 
disability on the EDSS and poor scores on the MSFC. Further analysis 
showed that the employed MS group performed better than the early 
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retirement group on the PASAT and SDMT. However, no cognitive test was 
found to be an independent predictor of early retirement in MS. 
 
4.2.1.10 Multitasking in multiple sclerosis: can it inform 
vocational functioning? 
 
The study by Morse and colleagues investigated the relationship 
between multitasking ability and whether a person managed to retain their 
work hours or had to reduce them (Morse, Schultheis, McKeever, & Leist, 
2013).  
30 PwMS were recruited from an outpatient clinic in America and were 
separated into two groups according to vocational status: cutback-
employment (including unemployed people) and same-employment. 
Multitasking ability was assessed using the SET and participants completed 
the following neuropsychological battery: COWAT, PASAT, SDMT, TMT, Zoo 
Maps and WASI. Mood and fatigue were assessed using the BDI-II and the 
FSS respectively. Information on changes to working hours was self-reported. 
The cutback-employment group had significantly slower CompletionSET 
scores compared with the same-employment group and it was concluded that 
decreased multitasking ability had a negative effect on employment outcome. 
Fatigue was also found to have a significant effect on employment outcome 
and accounted for over half the variance in employment outcome. It was also 
noted that using a total profile score of SET resulted in the loss of qualitative 
information about the individual’s performance. This information is particularly 
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useful in a clinical population which has a heterogenous presentation of 
cognitive difficulties, such as MS. 
 
4.2.1.11 Unemployment in multiple sclerosis: the contribution 
of personality and disease. 
 
Strober’s group researched the impact of personality type on 
employment status for PwMS in comparison to the following disease related 
variables: neurological and cognitive impairment, fatigue, mood and 
demographics (Strober et al., 2012).  
Data were taken from the baseline of a clinical trial on cognition in 
America. Employment status was used to form two groups: “unemployed”, 
which consisted of disabled PwMS, and “employed”, which consisted of paid 
workers, students, homemakers and volunteers. Participants were required to 
completed measures of mood, fatigue and personality. EDSS scores were 
calculated and a neuropsychological battery comprised of the COWAT, JOLO, 
PASAT, SDMT, SRT, 10/36 SPART and the sorting task from the DKEFS was 
administered.  
The employed group performed significantly better on the SDMT and 
SRT compared with the unemployed group. Regression analysis found that 
EDSS score, SDMT performance and the personality trait “persistence” 
accounted for 24% of the variance in employment status. SDMT performance 
was found to be a critical predictor of employment status, having a large effect 
size of d = 0.8. 
45 
 
4.2.1.12 Predicting employment status in multiple sclerosis 
patients: the utility of the MS Functional Composite. 
 
Honarmand’s group investigated how much demographic, personality 
and psychological variables impacted employment outcomes in MS in addition 
to cognitive and physical abilities (Honarmand, Akbar, Kou, & Feinstein, 
2011).  
62 PwMS were recruited from a Canadian clinic and were asked to 
complete a battery of tests. Neurological status was assessed using the 
MSFC and EDSS scores. The BRB-N was used to assessed cognitive ability, 
mood was assessed using the HADS and personality was assessed using the 
NEO-FFI.  
The study found that unemployed PwMS were more likely to be female, 
have progressive subtypes of MS and longer disease duration. They had 
poorer EDSS and MSFC scores, greater levels of depression and scored 
lower on the personality scales of extraversion and agreeableness. There 
were significant group differences on the SDMT, PASAT-3.0, PASAT-2.0 and 
WLG with employed PwMS scoring higher on these tests. There was no 
difference in the overall levels of cognitive impairment between the two 
groups. The MSFC was found the be the most robust predictor of employment 
status as it incorporates measures of physical and cognitive ability. 
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4.2.1.13 Demographic, clinical, and cognitive characteristics 
of multiple sclerosis patients who continue to work 
 
The study by Beatty and colleagues aimed to identify the factors which 
resulted in unemployment in MS (Beatty, Blanco, Wilbanks, Paul, & Hames, 
1995).  
102 PwMS were recruited from neurology practices and local support 
groups in America. Participants were separated into two groups: employed 
and retired and completed a large battery of neuropsychological tests to 
assess verbal ability, attention and concentration, information processing 
speed, naming, visuospatial perception, memory and problem solving. 
Participants also completed the BDI, a visual acuity test, the AI and a 
handedness inventory.  
PwMS who were employed performed better on cognitive measures than 
their unemployed counterparts. There was a significant difference in 
performance on digit span, LOT and the percentage of perseverative 
responses on the WCST.   
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Table 3: Summary of Results 
Author 
(First name 
and year) 
 
 
Quality 
Assessment 
Study 
design 
Recruitment 
Location 
Sample size 
and type of 
MS 
Employment 
Definitions Measures Outcomes 
Beatty 
(1995) 
Weak Cross 
Sectional 
Neurology 
practices, 
Support groups 
102, 
Clinically 
definite MS  
 
Employed (full 
time, part time, 
attending 
college at least 
part time) vs 
retired  
 
“housewife” or 
“househusband” 
not considered 
employed. 
BDI, visual acuity, AI, 
handedness. SILS, WAIS-R 
Digit Span, letter fluency 
and category fluency. 
SDMT, BNT, Benton Line 
Orientation, SMT, New Map 
Test, SRT, WCST, SILS 
abstraction test. 
Employed 
patients better 
cognitive 
performance. 
STM-Correct, 
SRT recall, 
FAS significant 
predictors of 
employment.  
Benedict 
(2016) 
Moderate Case 
Control 
Study 
Retrospective 
analysis of data 
from PwMS. HC 
recruited 
275 clinically 
definite MS, 
114 HCs 
“Gainfully” 
employed (not 
including people 
who have left 
MSFC, BICAMS. 
General employment 
information, 
work related problems or 
MS Work 
Disabled group 
consistently 
performed 
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through 
advertising 
the workforce 
voluntarily i.e. 
students and 
homemakers) 
 
MS Work Stable 
(full time 
employment, no 
disability 
benefits, no 
negative work 
events), 
MS Work 
Challenged 
(employed but 
having 
significant 
difficulties at 
work), 
MS Work 
accommodations, specific 
negative work events 
 
worse in 
comparison to 
the other 
groups. 
Followed by 
MS Work 
Challenged and 
MS Work 
Stable. HC 
Work Stable 
group had the 
best 
performance 
consistently 
across tests. 
All motor and 
cognitive tests 
significantly 
differentiated 
the three MS 
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Disabled 
(unemployed 
and receiving 
well defined 
monetary 
benefit e.g.: 
private disability 
benefits) 
HC Work Stable 
(employed, no 
negative work 
events) 
groups. T25FW 
was the only 
test with scores 
that were 
significant 
different 
between the 
MS Work 
Stable and HC 
Work Stable 
groups. SDMT 
the most 
discriminating 
cognitive test. 
Campbell 
(2016) 
 
Moderate Cross 
sectional 
MS Clinics 62, clinically 
definite MS 
Employed vs 
unemployed 
EDSS. BICAMS, EuroQOL, 
FAMS, PAM, USE-MS, 
HADS, MSNQ, FSS 
Patients with 
cognitive 
impairment on 
more than one 
test more likely 
to be 
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unemployed. 
SDMT most 
significant 
predictor of 
unemployment, 
after adjusting 
for education. 
Frndak 
(2015) 
 
Weak Mixed 
design: 
Cross 
sectional 
and 
prospecti
ve. 
Unknown Cross 
sectional 
sample: 
143, 
clinically 
definite MS.  
 
 
Longitudinal  
sample: 107 
(47 
overlapped 
with cross 
Employed: 
more than 10 
hours a week 
(not self- 
employed) 
 
(Employed 
PwMS only) 
Online survey work status 
(Demographics, disease 
characteristics, self-reported 
symptoms, DSQ General 
employment information, 
work-related 
problems/accommodations), 
T25FW, 9-HPT, CVLT-II, 
BVMTR, PASAT, BDI-FS, 
EDSS obtained for 103 
people. 
No significant 
impact of 
neuropsycholo
gical 
performance on 
the decision to 
disclosure MS 
status. 
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sectional 
group.) 
Goverover 
(2015) 
Moderate Cross 
sectional 
Advertisements, 
support groups, 
participant 
database at 
Kessler 
Foundation. 
72, clinically 
definite MS 
Employed full 
time or part time 
vs Unemployed 
or Disabled.  
 
Retirees (due to 
age) not 
included.  
MACFIMS, Sorting Task 
(from DKEFS), CMDI, STAI,  
Employment 
status 
significantly 
correlated with 
worse 
performance on 
measures of 
processing 
speed and 
visual memory 
(SDMT & 
BMVT-R) 
Honarmand 
(2011) 
Moderate Cross 
Sectional 
MS clinics 106, 
confirmed 
MS.  
Employed vs 
unemployed 
EDSS, MSFC, BRB-N, 
HADS, NEO-FFI 
Unemployed 
people 
significantly 
worse on 
SMDT, PASAT 
3.0, PASAT 2.0 
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and WLG. 
MSFC 
accounted for 
30.9% of the 
variance. 
Kordovski 
(2015) 
Strong Case 
control 
study 
Tertiary MS 
Centre. 
Controls 
recruited 
through 
advertisements. 
138, 
clinically 
definite MS 
  
Employed: 30 
hours+ per 
week. 
 
(PwMS 
Employed only) 
MSNQ, general 
employment information, 
negative work events, 
PDDS, T25FW, 9-HPT, 
SDMT (oral), PASAT, 
CVLT-II, BVMTR, BDI-FS. 
MS group 
cognitively 
impaired 
compared with 
controls.  
Work 
challenged 
participants 
performed 
significantly 
worse on 
T25TW, NHPT, 
PASAT, BVTR 
Delay, CVLT-II 
total learning. 
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MS participants 
experiencing 
challenges at 
work reported 
using cognitive 
accommodatio
ns more 
frequently. 
Krause 
(2013) 
Strong Case 
Control 
Study 
MS Clinic  
Control group 
recruited 
through local 
postings. 
87, clinically 
definite MS 
37 Healthy 
controls 
Employed vs 
Early retirement 
due to MS 
EDSS, MSFC, BRB-N, 
SRT, 10/36 SPART, 
PASAT, WLG, CES-D, 
MFIS, HrQoL, FAMS, KKG, 
(German questionnaire 
Health Locus of Control). 
Differences in 
cognitive 
scores between 
groups. Early 
Retirement MS 
group were the 
worst 
performing 
group. 
Significant 
differences 
between Early 
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Retirement MS 
and Employed 
MS groups on: 
SMDT and 
PASAT. Early 
Retirement 
group differed 
from controls 
on SRT-CLTR, 
SPART-DR, 
SDMT, PASAT 
3.0 and 2.0. No 
individual 
cognitive 
measure found 
to be a 
predictor of ER. 
Morse 
(2013) 
Moderate Cross 
sectional 
MS Clinic 30, clinically 
definite MS 
Cutback 
Employment 
(including 
SET, COWAT, PASAT, 
MSFC, SDMT, Trail making 
test, Zoo maps, Vocabulary 
Significant 
correlations 
between 
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unemployed) 
(hours cut back 
due to MS, 
included 
unemployed) vs 
Maintained 
Employment. 
(Employment: 
Services 
provided for 
compensation 
over the last 30 
days. 
Unemployment 
= no hours of 
work) 
(WASI for premorbid IQ).  
BDI-II, FSS 
completion of 
SET and 
SMDT. SET 
profile also 
correlated with 
COWAT z test 
score. Cutback 
employment 
group had 
significantly 
lower SET 
scores 
compared with 
same 
employed 
group. SET a 
significant 
predictor of 
vocational 
status. Overall 
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executive 
function not 
retained as 
significant 
predictor.  
Strober 
(2012) 
Moderate Cross 
sectional 
Baseline data 
taken from 
drugs trial. 
101, 
clinically 
definite MS. 
 
Employed (paid 
worker, 
volunteer 
worker, student, 
homemaker) vs 
Unemployed 
(disabled). 
Retired people 
excluded. 
Occupational Functioning 
Questionnaire, CMDI, FSS, 
TPQ, EDSS, COWAT, 
JOLO, PASAT, SDMT, 
SRT, 10/36 SPART, Sorting 
task (DKEFS). 
Unemployed 
group 
performed 
worse on 
cognitive 
measures. 
Lower mean 
scores on all 
cognitive tests. 
Only significant 
for SDMT, and 
SRT. SDMT a 
significant 
predictor of 
employment 
57 
 
status through 
regression 
analysis with 
effect size of 
0.8. 
Van der 
Hiele 
(2015) 
Strong cross 
sectional 
Dutch MS and 
employment 
inventory. 
55, RRMS 
only.  
Employed (full 
time, part-time) 
vs Unemployed 
(without a paid 
job including 
homemakers, 
volunteers, 
patients 
receiving 
disability 
allowance or 
unemployment 
benefits, on 
prolonged 
medical leave 
BADS DEX (self-report) 
NART, Trail Making Test, 
Stroop, PASAT, WCST, 
Rey Complex Figure (copy 
only), BADS, HADS, FIS.  
Patients with 
paid 
employment 
completed 
more 
categories on 
WCST. No 
group 
differences in 
premorbid 
intelligence or 
other types of 
executive 
functioning. 
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or early 
retirement) 
Vanotti 
(2017) 
Moderate Cross 
Sectional 
MS Clinics 50, clinically 
defined MS 
Unemployed 
specifically 
because of 
disability vs 
Unemployed for 
reasons 
unrelated to 
disability. 
BICAMS (Spanish version 
of CLVT-I used, not CLVT-
II), MSNQ-Informant and -
Patient (Argentinian 
adaptation), EDSS, MSFC, 
BDI-FS, FSS 
Strong 
association 
between the 
BICAMS and 
work hours. 
Employment 
status a 
predictor of 
CLVT-I 
performance.  
Walker 
(2016) 
Moderate Prospecti
ve study, 
case 
control 
MS Clinics. 
Controls 
recruited by 
word of mouth. 
57 PwMS, 
clinically 
defined MS.  
51 healthy 
controls 
Self-reported 
vocational 
status.   
 
BICAMS (alternate forms 
used for follow-up), MSNQ 
(informant and self-report), 
PHQ-9, MFIS, EDSS 
Case control 
group: BVMT-R 
and EDSS 
score used in 
regression. Full 
model 
significantly 
predicted 
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employment. 
Model 
accounted for 
23.6-32.8% of 
the variance in 
employment 
status. 
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4.3 Quality Assessment. 
The results of the quality assessment are presented in Table 4 below. 
The majority of studies found were rated as “moderate” or “strong”. Two 
studies were rated as “weak” (Beatty et al., 1995; Frndak et al., 2015). Both 
studies had weak participant selection methods and study design. The study 
by Frndak (2015) did not mention if there was any attrition from their 
longitudinal group or reasons for people deciding drop-out. No studies were 
removed from this review as a result of their quality assessment.  
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Table 4: Table of Results of Quality Assessment 
Study (first 
author, year) 
Selection 
Bias 
Study 
Design 
Confounders Blinding Data 
collection 
Method 
Withdrawals 
and Dropouts 
Overall 
Quality 
Rating 
Beatty (1995) Weak Weak Strong Moderate Strong N/A Weak 
Benedict (2016) Moderate Moderate Strong Moderate Strong N/A Moderate 
Campbell (2016) Moderate Weak Strong Moderate Strong N/A Moderate 
Frndak (2015) Weak Weak Strong Moderate Strong Weak Weak 
Goverover (2015) Strong Weak Strong Moderate Moderate N/A Moderate 
Honarmand 
(2011) 
Moderate Weak Strong Moderate Strong N/A Moderate 
Kordovski (2015) Moderate Moderate Strong Moderate Strong N/A Strong 
Krause (2013) Moderate Moderate Moderate Moderate Strong N/A Strong 
Morse (2013) Moderate Weak Strong Moderate Strong N/A Moderate 
Strober (2012) Moderate Weak Moderate Moderate Strong N/A Moderate 
Van der Hiele 
(2015) 
Moderate Moderate Strong Moderate Strong N/A Strong 
Vanotti (2017) Moderate Weak Strong Moderate Strong N/A Moderate 
Walker (2016) Moderate Moderate Strong Moderate Strong Weak Moderate 
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4.4  Demographics 
The majority of the studies were conducted in the North American 
continent (n=9), followed by Europe (n=3) and South America (n=1). 
The 13 studies included a total of 1278 participants with MS. PwMS 
were frequently recruited from outpatient or community settings. One study 
used a database and support groups for recruitment, two studies analysed 
retrospective data and one study did not specify their source of participants. 
972 PwMS were female (76.1%) and the remaining 306 were male (23.9%).  
Most PwMS were diagnosed with Relapsing Remitting MS (n=921, 
72.1%). This was followed by Secondary Progressive MS (n=177, 13.8%), 
Primary Progressive MS (n=45, 3.5%), Clinically Isolated MS (n=7, 0.5%) and 
Progressive Relapsing MS (n=4, 0.3%). This reflects the  breakdown of the 
subtypes of MS within the population (Bishop & Rumrill, 2015). 21 people did 
not know what type of MS they had been diagnosed with (1.6%) and 103 were 
unspecified (8.1%). Studies which had participants with unspecified diagnoses 
recruited through databases (Goverover et al., 2015), conducted a 
retrospective analysis on data (Benedict et al., 2016) and were reliant on a 
self-reported diagnosis (Frndak et al., 2015). Despite recruiting from MS 
clinics, two studies were unable to obtain a confirmed diagnosis of MS from a 
neurologist and did not specify reasons why this was the case (Honarmand et 
al., 2011; Kordovski et al., 2015) 
There was a total of 263 healthy control participants over the four studies 
which included control groups. 187 of these participants were female (71.1%), 
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whilst the remaining 76 were male (28.9%). Control participants were 
recruited by word of mouth or through advertisements in the local community. 
4.5 Measures Used  
4.5.1 Neuropsychological Batteries. 
A variety of different neuropsychological tests were used in the final 13 
studies. The most commonly used test was the PASAT, which was used in 
five studies, followed by the BICAMS battery, which was used in four studies. 
It is worth noting that the PASAT also forms part of the MACFIMS battery, 
which was used by one study, and the BRB-N, which was used by two 
studies. The PASAT is also the cognitive component of the MSFC, which was 
used in five studies. Although the MSFC contains a cognitive test, the PASAT, 
it also contains two motor tests. Therefore, the MSFC will only be discussed 
where appropriate. 
The most commonly assessed cognitive domain was processing speed, 
which was tested 19 times across the 13 studies, and working memory which 
was tested 14 times. 
4.5.2 Definitions of Employment. 
Employment information was self-reported in each study. Many studies 
dichotomised employment status into “employed” and “unemployed”. 
However, the precise definitions of these terms, and therefore people 
excluded or assigned to these groups, varied. Three studies grouped 
participants using the terms “employed” and “unemployed” without further 
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explanation of what was considered “employed” or taking into account 
reasons for unemployment.  
One study defined employment as “working 30 hours a week or more”. 
Another study excluded self-employed people and people working less than 
10 hours per week. Four studies created groups which were “employed” and 
“unemployed or retired due to MS”, thus excluding people who were retired 
due to age from their unemployed group. One of these studies also included 
people who self-identified as disabled in their unemployed group.  
One paper included people who were not engaged in paid employment 
in their unemployed group, i.e. volunteers, homemakers, participants 
receiving disability benefits, people on long-term medical leave and people 
who had taken early retirement.  
Another paper also grouped participants into employed and retired, 
however included part-time students in the employed group. In that particular 
study homemakers were not considered employed. Another study specified 
that employment had to be “gainful”. It also used a questionnaire to form three 
functional anchor groups for PwMS. These groups were defined not only by 
employment status, but also by the number of negative work events and 
accommodations that had to be made. 
One study looked at the relationship between MS and employment hours 
rather than employment status.  
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4.6 Cognition 
12 of the studies in this systematic review found that there was a 
relationship between employment status and cognition in MS. Namely, poorer 
scores on cognitive tests and impairment on a greater number of tests were 
significantly related to unemployment or reduced hours of work. Although this 
relationship between cognition and employment status or hours worked was 
found in the majority of papers, there was not a significant difference between 
groups on all cognitive tests administered.  
For example, Beatty and colleagues (1995), assessed a broad range of 
cognitive abilities: verbal ability, attention-concentration, information 
processing speed, naming, visuospatial perception, memory and problem 
solving abstraction. Non-significant differences were found for attention-
concentration (digit span), visuospatial perception and preservative responses 
on the WCST.  
The remaining study was investigating the factors related to the 
disclosure of MS in the workplace (Frndak et al., 2015). Thus, there were no 
inferential statistics relating to the impact of cognition on work performance. 
This study did find that there was no significant relationship between cognition 
and the decision to disclose MS status to employers. This is in contrast to the 
results for the relationship between physical disability and the decision to 
disclose and of course, physical disabilities are more apparent to work 
colleagues or employers. 
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4.6.1 Information Processing Speed. 
Many of the studies found that information processing speed was 
significantly related to employment status. In these studies, employed PwMS 
had better scores on tests of information processing speed in comparison to 
their unemployed peers.  
Beatty and colleagues (1995) found that performance on a timed 
phonemic fluency task was a significant predictor of employment status. 
Whilst phonemic fluency tasks are typically considered to be tests of 
executive function, the timed element means that general information 
processing speed may impact performance (Henry & Beatty, 2006).  
The SDMT is a test that is frequently used to assess processing speed 
in this population. A significant difference in performance in groups of 
unemployed and employed participants with MS was observed on this test in 
several studies (Benedict et al., 2016; Campbell et al., 2016; Goverover et al., 
2015; Honarmand et al., 2011; Strober et al., 2012). Performance on the 
SDMT was also seen to be a significant predictor of work hours amongst 
PwMS (Vanotti et al., 2017) and employment status (Benedict et al., 2016; 
Campbell et al., 2016; Strober et al., 2012; Vanotti et al., 2017). Furthermore, 
Krause and colleagues found that there was a significant difference between 
PwMS who had retired early and employed PwMS (2013). In addition, the 
study by Benedict and colleagues (2016) found that performance on the 
SDMT was significantly different between their three MS anchor groups and 
was the most discriminating cognitive task in their study. It was also the only 
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test with significantly different results for the MS Work Stable group and the 
Healthy Control group. 
The PASAT, which was the most commonly used test, was also able to 
distinguish between groups of unemployed and employed PwMS. Honarmand 
and colleagues (2011) found that two speeds of delivery of the PASAT 
(PASAT 3.0 and the PASAT 2.0) were both able to significantly differentiate 
between groups of employed and unemployed PwMS. In addition, a binary 
logistic regression found that the MSFC, which includes the PASAT, 
accounted for 30.9% of the variance in scores for employed and unemployed 
PwMS. Krause and colleagues (2013) also found that PwMS with reduced 
working hours also performed worse on the PASAT-3.0 in comparison to 
PwMS who continued to work as before. Moreover, healthy controls 
significantly outperformed both these groups on the same task. Benedict and 
colleagues (2016) found that their MS anchor groups had significantly 
different results on the PASAT, however there was no significant difference 
between the employed MS Work Stable group and the Healthy Control group. 
Moreover, a ROC curve analysis found that the PASAT was not a test that 
could be used to accurately discriminate between their anchor groups. 
 
4.6.2 Memory. 
There were significant differences between groups on tasks of memory 
recall. The BVMT-R is an immediate visual memory recall task that was able 
to differentiate between groups of employed and unemployed PwMS in some 
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of the studies in this review. Poor performance on the BVMT-R was 
significantly associated with unemployment (Goverover et al., 2015) and was 
a significant predictor of employment status (Walker et al., 2016). The study 
by Beatty’s group also found that the number of correct responses on the 
STM was a significant predictor of employment status (1995). Similarly, 
Vanotti and colleagues (2017) found that the CVLT-I, a measure of verbal 
immediate recall, was significantly related to employment status and work 
hours, as well as being a significant predictor of unemployment with a large 
effect size. In addition, Kordovski’s group found that total learning on the 
CVLT-II was significantly worse for employed PwMS who were reporting 
challenges at work (Kordovski et al., 2015). Benedict’s group found that there 
was a significant difference in performance on the CVLT-II overall between 
the MS group and the healthy control group, as well as between the different 
MS anchor groups. However, the CVLT-II was not a significant discriminator 
for the different MS anchor groups (Benedict et al., 2016). 
There were also significant differences seen on tasks of long term 
memory. Performance on the delayed trial of the SRT was also shown to be 
significantly different amongst unemployed and employed PwMS by Strober 
and colleagues (2012). Beatty and colleagues found that the delayed trial of 
the SRT was a significant predictor of unemployment in MS (1995).  
 
 
 
69 
 
4.6.3 Executive Function. 
There were many different tests of executive function used in the 12 
studies found, however there were few significant differences in performance 
between groups of employed and unemployed PwMS. Van der Hiele’s group 
found that people with RRMS who were in paid employment completed 
significantly more categories on the WCST in comparison to their peers who 
were not in paid employment (2015). This suggests that people with RRMS in 
paid employment were better at idea generation and set shifting. This study 
found no significant difference on other measures of executive function.  
A study by Morse and colleagues (2013) found that PwMS who were 
able to maintain their work hours performed significantly better on the SET, a 
multitasking task. Honarmand’s group found that unemployed PwMS 
performed significantly worse than employed PwMS on the WLG, a task of 
verbal fluency (Honarmand et al., 2011). A similar outcome was found by 
Beatty and colleagues on a tests of semantic and phonemic fluency (1995).  
However, this result on the WLG was not replicated by Krause’s group (2013). 
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5 Discussion 
5.1 Summary of Main Findings 
This systematic review was conducted to investigate the relationship 
between cognitive ability in MS and employment outcomes for working age 
people of this population.  
One study which investigated the relationship between cognition and 
disclosure of MS status to employers found that there was no significant 
relationship between cognition and disclosure. The remaining 12 studies 
which looked explicitly at the relationship between cognition, employment and 
unemployment, found that PwMS who were unemployed or who had reduced 
their working hours performed worse on cognitive tests in comparison to 
PwMS who had no change to their employment status or hours. It is worth 
noting that these group differences did not always reach statistical 
significance. Studies that included a control group found the control group 
performed better than both unemployed and employed PwMS.  
One of the most consistent findings was the difference in information 
processing speed between groups. This effect was seen in half of the studies 
in this systematic review and irrespective of the type of information processing 
task administered as part of the battery. In some studies, scores on tasks of 
information processing were able to significantly predict employment status 
using regression modelling. Given the prevalence of information processing 
speed deficits in MS and the hypothesis that it is the cause of other cognitive 
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impairments in this population, it is not surprising that it was one of the most 
consistent deficits identified in this review (Costa, Genova, DeLuca, & 
Chiaravalloti, 2017; M. A. Drew, Starkey, & Isler, 2009; Forn, Belenguer, 
Parcet-Ibars, & Avila, 2008). Not only can slowed processing affect 
performance on other cognitive tests, but it can also impede performance in 
the workplace. For example, on the completion of time sensitive tasks or 
generally needing more time to problem solve difficulties. 
Differences in immediate and delayed recall were also observed to be 
significant between groups. Short term memory was impaired across both 
verbal and visual modalities and tasks of short term memory were able to 
significantly predict employment status. Two studies found that the 
performance of people who were unemployed was significantly worse on the 
SRT delay trial in comparison to employed PwMS. 
There was also a relationship between certain executive functions and 
employment, specifically on tasks requiring idea generation, and set shifting. 
Once again, PwMS who were employed or who were able to maintain their 
premorbid working hours performed better than people who had to make 
changes to their employment because of their MS. It is worth noting that the 
majority of the studies were cross sectional, and therefore it is possible that 
unemployment resulted in cognitive difficulties in this group rather than being 
the result of them. 
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5.2 Methodological Critique of Studies 
Using the EPHPP as a measure for a quality assessment of the studies 
in this review found that eight studies were rated as “moderate”, three were 
rated as “strong” and two were rated as “weak”.  
One of the difficulties encountered was that the majority of the studies, 
seven in total, were cross-sectional observational studies. These studies often 
created groups of unemployed or employed people using demographic data 
collected after recruitment, rather than deliberately recruiting a particular 
group.  
The EPHPP was created to evaluate research investigating new 
interventions (Armijo-Olivo, Stiles, Hagen, Biondo, & Cummings, 2012; 
Thomas et al., 2004). It is a well-used quality evaluation tool and its 
accompanying dictionary of terms makes it easy to use. Furthermore, its use 
was recommended in a systematic review evaluating quality assessment tools 
(Deeks et al., 2003).  
Since the EPHPP evaluates intervention studies, randomised control 
trials (RCTs), often considered the “gold standard” approach for such 
research, are rated as a strong methodological approach. Conversely, studies 
which are observational, investigating relationships between variables 
involving other methodologies, are rated as “moderate” or “weak” despite 
being the best approach for answering their research question or aims.  
An improvement on this systematic review might be to use a quality 
assessment tool specifically created for observational, cross-sectional studies.  
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5.3 Limitations and suggestions for future research 
The different definitions of “employment”, “unemployment” and “retired” 
used across the 13 papers means that there is some degree of heterogeneity 
and that people considered employed in one study may not be considered 
employed in another. Despite the relative consistency of the findings in these 
studies, it is possible that this difference may impact results. It may be that the 
development of standardised definitions of “employment” and “unemployment” 
would be useful in further research. This could include ensuring that 
unemployment or a reduction of working hours being described is a direct 
result of the symptoms of MS since people may choose to leave work or 
reduce their hours for many reasons. 
None of the papers described in this review took into account the type of 
job or sector that people were currently or had been employed in as part of 
their analyses. It is possible that different types of employment (skilled, 
unskilled, manual, etc) may be affected by particular cognitive difficulties due 
to the nature of the work involved. As highlighted by Vanotti and colleagues 
(2017), countries or regions which have industries dependent on manual 
labour may see a greater impact of physical impairments rather than cognitive 
impairments.  
Of note, there are no studies from the Asian, Australasian or African 
continents. This may reflect the global geographical spread of MS and the 
lower prevalence rates in these areas, however given the mix of industries 
across the continents, it would be interesting to compare data from these 
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regions to studies from North America and Europe (Leray, Moreau, Fromont, 
& Edan, 2016; Wade, 2014). 
There is also variation in the employment rates due to MS across 
Europe. These rates range from 28% in Russia to 64% in Denmark and it may 
be that there are socioeconomic or political reasons behind these differences 
(Kobelt et al., 2017). For example, a country which provides disability or 
sickness benefits may find that there is a higher rate of unemployment in MS 
as it is a more financially viable option in comparison to a country with little or 
no financial aid for people with disabilities or chronic health conditions. These 
socioeconomic factors were not considered by the studies in this review. 
Neither were gender differences. MS is more prevalent in women than in men 
and it may be that attitudes about gender roles also affect the decision to 
withdraw from the workforce (Thompson et al., 2018). 
It should be a priority to manage employment challenges for PwMS and 
help them to maintain or regain their employed status should they so wish. 
Australia has demonstrated impressive, real gains in employment rates for 
PwMS by facilitating work adjustments and guidance is available for health 
professionals to address this issue (Cardone, 2017; Van Dijk, Kirk-Brown, 
Taylor, & van der Mei, 2017). However, for some people, retiring due to MS is 
the right thing for them to do and they may not consider it to be a loss or 
detrimental to their quality of life. It is important that these decisions are 
respected by clinicians.  
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6 Conclusion 
The aim of this review was to provide a synthesis of the literature about 
the impact of cognition on employment outcomes for PwMS. The findings 
were that PwMS who were unemployed or had reduced working hours had a 
greater level of cognitive impairment than PwMS who remained employed or 
maintained their working hours. Employed PwMS still had greater levels of 
cognitive impairment than healthy controls. Information Processing Speed, 
short-term memory delayed recall and executive functions were the domains 
that were frequently significantly different between the two groups. Further 
research might focus on identifying meaningful benchmarks of impairment in 
these areas which are related to employment for PwMS, building on the work 
that has already started in this area (Benedict et al., 2016).  
The need to have a more consistent definition of “employment” was 
highlighted by this review as was the need to clarify reasons for 
unemployment within this group.  
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7 Paper II: Assessment of Executive Function in 
Multiple Sclerosis using a Virtual, Office-Based 
Task and its Relationship to Employment 
Performance 
7.1 Abstract 
Multiple Sclerosis (MS) is a chronic and progressive disease which is 
characterised by inflammation, demyelination of neurons and formation of 
plaques at several sites in the Central Nervous System. Unemployment can 
be a major challenge for people with MS (PwMS). Impairments in executive 
function in MS have been linked to employment difficulties and the use of 
maladaptive coping strategies. Accurate assessment of executive function is 
therefore important for helping individuals develop management strategies at 
home and at work.  
The Jansari Assessment of Executive Function (JEF©) is a non-immersive 
virtual reality test which takes place in an office environment. It has been 
shown to be sensitive to deficits in executive function in other clinical and non-
clinical populations. This study aimed to compare the sensitivity of the JEF© 
to other traditional executive function tests in MS, as well as determine if the 
results of the JEF© were more closely correlated to coping styles and 
employment outcomes than these existing tests.  
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A total of 18 PwMS and 24 Healthy Controls (HC) took part in this study. All 
participants completed the JEF©, a battery of traditional executive function 
neuropsychological tests, the BICAMS and questionnaires about employment 
difficulties, mood, anxiety, fatigue and coping styles.  
PwMS had significantly poorer scores on the JEF© Total Score, JEF© 
creative-thinking and JEF© Action-Based Prospective Memory subscales. 
There was a significant difference between groups on the employment 
questionnaires and a significant negative correlation between JEF© Total 
Score and employment questionnaires. The only coping scale which showed 
a significant between group difference was Maladaptive Coping, with the HC 
group using more of these strategies.  
There were significant positive relationships between the JEF© Total Score 
and Adaptive Coping subscale, and the composite Executive Function Index 
and Adaptive Coping subscale, but no significant difference in the strengths of 
these correlations.  
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Unemployment can be a major challenge for people with Multiple 
Sclerosis (MS). Although one might expect difficulties with employment to 
eventually accompany a degenerative disease, such as MS, in its later 
stages, studies have shown that even people with minimal physical disabilities 
can have difficulties maintaining employment (Kobelt et al., 2017).  
Research has shown that cognition is a mediating factor between 
disability and unemployment in this population and that executive function is 
one of the cognitive domains which has specifically been linked to 
unemployment (Cadden & Arnett, 2015; M. Drew, Tippett, Starkey, & Isler, 
2008; Van der Hiele et al., 2015).  
Assessment of cognitive ability is essential for successful management 
of the disease. The Jansari Assessment of Executive Function (JEF©) is a 
new assessment utilising non-immersive virtual reality which could be used to 
evaluate executive dysfunction in this group.  
 
7.2 Multiple Sclerosis 
MS is a chronic and progressive disease which is characterised by 
inflammation, demyelination of neurons and formation of plaques at several 
sites in the Central Nervous System (CNS) (Kutzelnigg & Lassmann, 2014; 
Milo & Miller, 2014; Nylander & Hafler, 2012; Polman et al., 2011). The myelin 
sheath surrounding neurons supports the propagation of action potentials 
along the neuron through the process of saltatory conduction at the nodes of 
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Ranvier. Damage to the myelin sheath therefore disrupts the transmission of 
action potentials in the CNS (Kolb & Whishaw, 2008).  
MS is a heterogenous disease, however it can be divided into three main 
subtypes: Relapsing Remitting, Secondary Progressive and Primary 
Progressive. Approximately 80-90% of patients will be diagnosed with 
Relapsing Remitting MS (RRMS) following an initial Clinically Isolated 
Syndrome - a single demyelinating event. RRMS is characterised by periods 
of relapse followed by periods of clinical stability where the individual can 
return to their pre-relapse level of function. 40% of people with RRMS will 
then go on to develop Secondary Progressive MS (SPMS) within 10 years of 
their initial diagnosis. SPMS is characterised by an irreversible progression of 
the disease. 10-15% of people will be diagnosed with Primary Progressive MS 
(PPMS) which is distinguished by a progressive course from the outset 
(Iwanowski & Losy, 2015; Milo & Miller, 2014; Nylander & Hafler, 2012). 
It is estimated that 2.3 million people in the world have MS, with 30 being 
the average age of diagnosis (Milo & Miller, 2014). MS has a significant 
impact on quality of life and is one of the major causes of disability for young 
people in the world, with 50-80% of people becoming unemployed within 10 
years of diagnosis and a reduced life expectancy in comparison to the general 
public. (Lunde et al., 2017; Wicks et al., 2016).  
Symptoms of MS vary greatly and include a range of physical difficulties 
such as numbness, visual disturbances, dizziness, ataxia, fatigue, poor 
coordination, problems with gait, bladder and bowel dysfunction to name but a 
few (Milo & Miller, 2014; Wicks et al., 2016). There is also a higher rate of 
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psychological difficulties such as depression or anxiety in this population in 
comparison to the general public (Murphy et al., 2017).  
 
7.3 Cognitive Impairments in Multiple Sclerosis 
Cognitive impairment affects 40-70% of people with MS (Deluca et al., 
2015). It can be seen in all subtypes and stages of the disease and is 
associated with lesions and atrophy of grey and white matter in the CNS. 
People with MS (PwMS) who have cognitive impairment are more likely to be 
unemployed, have mental health difficulties and have more problems with 
activities of daily living (Grech et al., 2017b). Cognitive impairments, therefore, 
negatively impact quality of life for people in this population. Cognitive 
symptoms of MS typically include difficulties with processing speed and 
memory (Chiaravalloti & DeLuca, 2008; Grech et al., 2017b; Langdon, 2011; 
Rao et al., 1991; Roman & Arnett, 2016).  
PwMS may also have impaired executive function (Van der Hiele et al., 
2015). There are many theories regarding how executive function is organised 
and exactly what abilities fall under the label. However, it is generally agreed 
that “executive function” is an umbrella term describing the cognitive functions 
needed to successfully carry out goal-directed behaviours which require 
attention and concentration. There are three core executive functions from 
which the other, higher order executive functions stem: inhibition, working 
memory and cognitive flexibility. Other abilities include planning, organisation, 
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emotion regulation and problem solving (Diamond, 2013; Langdon, 2011; 
Miyake et al., 2000).  
Impairments in executive function are observed less frequently in this 
population in comparison to other cognitive domains such as processing 
speed (Ferreira, 2010). Nevertheless, studies have shown that PwMS perform 
significantly worse on traditional executive function tasks such as verbal 
fluency tests, the Wisconsin Card Sorting Test, as well as the Delis-Kaplan 
Executive Function System (DKEFS) (M. Drew et al., 2008; Henry & Beatty, 
2006; Parmenter et al., 2007). A relationship has also been seen between 
performance of tasks of executive function, functional status and the ability to 
carry out activities of daily living (Kalmar, Halper, Gaudino, Moore, & DeLuca, 
2008). Executive dysfunction can therefore have an impact on quality of life 
for people with MS.  
Poor executive function has been linked to the use of maladaptive 
coping strategies, such as avoidance, in the MS population. This in turn has 
been linked to increased psychological difficulties (Grech et al., 2017b). 
“Coping” refers to the collection of behaviours and thoughts which an 
individual uses to manage their emotions during times of stress. These 
stressors may be internal and/or external. Coping behaviours are used in 
order to regain a state of emotional equilibrium when an individual feels that 
their efforts to reach important goals are being thwarted (Folkman & 
Moskowitz, 2004).  
Although there are many factors which influence which coping strategy 
an individual chooses, it has been suggested that the executive functions of 
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cognitive flexibility, working memory and inhibition play key roles in the 
selection of the most appropriate strategy (Hofmann, Schmeichel, & 
Baddeley, 2012). The use of maladaptive coping styles has also been linked 
to higher rates of negative work events and unemployment within the MS 
population. This may be related to the increased focus on emotion and mental 
disengagement which the individual uses to cope with stress (Grytten et al., 
2016; Van der Hiele et al., 2016). 
 
7.4 Employment and Cognition in Multiple Sclerosis 
Up to 45% of PwMS with minimal disabilities, as measured by the 
Expanded Disability Status Scale (EDSS), are unemployed (Kobelt et al., 
2017). Research has shown that cognitive impairment is a mediating factor in 
the relationship between physical disability and unemployment for PwMS 
(Campbell et al., 2016; Deluca et al., 2015).  
The systematic review conducted as part of this thesis found that 
unemployment or reduced work hours are associated with poor performance 
on cognitive tasks. This was primarily seen in the areas of information 
processing speed, immediate recall, delayed recall and executive function. 
Please see section 4.6 (p. 65) of this thesis for further discussion of the 
relationship between employment and cognition in MS. 
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7.5 Adaptations and Accommodations used in the Workplace 
Accommodations are frequently used by PwMS to try and prevent their 
symptoms from interfering with their work responsibilities. Since the disease is 
heterogenous in its effect, people will need to have accommodations tailored 
to suit their needs and reviewed in the event of a relapse or deterioration. 
Adaptions to manage fatigue include rearranging the work day to 
economise energy, building in regular rest periods into the work day or being 
able to work from home. Ergonomic work stations and computer screens with 
options for text enlargement or changes in contrast can be used to help 
manage motor difficulties and visual disturbances respectively. Adaptations to 
help manage cognitive dysfunction include memory aids and calendars which 
can send reminders as texts or emails to prompt the individual. Structuring the 
day to maximise the use of routines and reducing cognitive load can also be 
beneficial, as can reducing the need for multitasking where possible 
(Benedict, Rodgers, Emmert, Kininger, & Weinstock-Guttman, 2014; Johnson 
& Bruyere, 2001). 
It is worth noting that for accommodations to be implemented, the 
individual needs to disclose that they have MS to their employers. 
Unfortunately, not all employees feel able to do this for fear of discrimination, 
being treated differently or having their managers doubt their capacity 
(Rumrill, Fraser, & Johnson, 2013). 
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7.6 Testing Executive Function within MS 
Accurate assessment of executive dysfunction is essential for 
developing management strategies (Frndak et al., 2016). However, there are 
some obstacles to this.  
There are many well-validated tests of executive function which are 
available to clinicians, such as the Wisconsin Card Sorting Test. Despite this, 
some of these tests lack ecological validity and do not reflect the impact of 
cognitive impairment in everyday life (Chaytor & Schmitter-Edgecombe, 
2003). For example, some of these tasks are highly structured by the 
examiner, thus taking away the burden of planning which is in itself an 
executive function. Nevertheless, the structure of traditional pen and paper 
neuropsychological tests means that there is a high degree of experimental 
control. There is therefore a trade-off between the need for ecological validity 
and experimental control (Bohil, Alicea, & Biocca, 2011; Parsons, 2015). 
Clinicians could ask patients to report on areas of difficulty, however self-
report can be biased by factors such as depression or other mental health 
problems common in MS, and the accuracy of self-report in the literature is 
inconclusive (Bruce, Bruce, Hancock, & Lynch, 2010; Hanssen, Beiske, 
Landrø, & Hessen, 2014; Smith & Arnett, 2010; Van der Hiele et al., 2012). 
Family members or carers of people with MS could be asked to provide 
collateral information, however this is still a subjective report, though closer to 
objective findings (Benedict et al., 2004).   
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There are currently some neuropsychological batteries and tests which 
have been designed with ecological validity in mind. The Behavioural 
Assessment of Dysexecutive Syndrome (BADS) is an example of an 
ecological valid test (Wilson, Alderman, Burgess, Emslie, & Evans, 1996). 
However, it still takes place within the artificial environment of the clinic room.  
The Multiple Errands Test (MET) is another example of an ecologically 
valid test (Shallice & Burgess, 1991). The MET is particularly note-worthy as it 
takes place in a shopping centre or hospital, rather than the clinic room. The 
participant is given a list of tasks, with associated rules by the administrator 
but are left to decide the best way to complete the tasks. This is contrary to 
other neuropsychological batteries made up of short, discrete subtests where 
order and task initiation is largely decided by the test administrator (Shallice & 
Burgess, 1991). Assessment in a real-world environment, such as a shopping 
centre, is advantageous as it gives a more accurate representation of ability 
than assessment in a clinic, however this is not always practical as service 
users may not be physically capable. In addition, it requires the consent and 
cooperation of local business which they may not be willing to provide. 
Virtual reality, both immersive and non-immersive, can be a way of 
achieving a compromise between ecological validity and experimental control 
for neuropsychological tests. Virtual reality tests have also been shown to be 
sensitive to executive dysfunction (Besnard et al., 2016; Davison, Deeprose, 
& Terbeck, 2017; Rand, Basha-Abu Rukan, Weiss, & Katz, 2009). They are 
also likely to be more engaging and portable than traditional pen and pencil 
neuropsychological tests. Furthermore, public responses to the use of virtual 
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reality in medical settings is generally positive (Dascal et al., 2017; Keller et 
al., 2017). 
 
7.7 The Jansari Assessment of Executive Function 
The Jansari assessment of Executive Function (JEF©) is a new, non-
immersive virtual reality test based on the MET but set in an office 
environment. It has been shown to be sensitive to dysexecutive symptoms in 
people with acquired brain injury, as well as to the effect of drugs which have 
only anecdotal reports of executive dysfunction undetected by other 
neuropsychological batteries, for example: nicotine, caffeine and ecstasy 
(Jansari et al., 2014; Jansari, Froggatt, Edginton, & Dawkins, 2013; 
Montgomery, Hatton, Fisk, Ogden, & Jansari, 2010; Soar, Chapman, Lavan, 
Jansari, & Turner, 2016). To date the JEF© has not been used in the MS 
population. Having results which accurately reflect real world experiences is 
necessary for improved disease management as well as being able to support 
PwMS in maintaining activities that are important to them, including 
employment. 
Since the JEF© has been shown to be more sensitive than other tests of 
executive function in other clinical and non-clinical populations, it is possible 
that it will provide results which are more accurate and more reflective of the 
experiences of PwMS with executive impairment than traditional pen and 
paper neuropsychological tests. 
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7.8 Aims and Hypotheses 
The aims of this study are as follows: to compare the sensitivity of the 
JEF© to existing traditional neuropsychological tests of executive function 
within the MS population and how they correlate with measures of 
employment performance and coping styles. 
As the JEF© has not been used in the MS population before, it will also 
be necessary to confirm that the JEF© is sensitive to deficits within this 
population. It is hypothesised that the JEF© will be sensitive to deficits in 
executive function in the MS population. In addition, the JEF© will be more 
closely correlated to employment outcomes and coping styles in comparison 
to the pen-and-paper neuropsychological tests. 
People with RRMS and healthy control participants will therefore be 
asked to complete the JEF© as well as the following traditional, pen-and-
paper neuropsychological tests of executive function: Zoo Maps and Key 
Search subtests from the BADS (Wilson et al., 1996) and a verbal fluency test 
(Henry & Beatty, 2006). Participants will be matched according to age and IQ 
using the Test of Premorbid Function, UK Version (TOPF-UK) (Wechsler, 
2011). Participants will also be required to complete the Brief International 
Cognitive Assessment for Multiple Sclerosis (BICAMS) (Langdon et al., 2012). 
All participants will complete questionnaires covering a range of work-
place experiences which may affect employment for people with MS. These 
are: the Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-Job) 
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(Schiavolin et al., 2016) and the Multiple Sclerosis Work Difficulties 
Questionnaire (MSWDQ) (Honan et al., 2012).  
Participants will also complete the COPE Inventory (Carver, Scheier, & 
Weintraub, 1989), which asks participants about their coping strategies. The 
Fatigue Severity Survey (Krupp, LaRocca, Muir-Nash, & Steinberg, 1989)  
and the Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) will 
also be administered to take into account confounding variables of mood and 
fatigue. Please see Appendix I for copies of the questionnaires used in this 
study. 
The scores on the JEF© and traditional neuropsychological tests will be 
compared to see if there is a significant difference between the MS group and 
the control group. Correlations will also be carried out to assess the 
relationship between results on the employment questionnaires, the JEF© 
and the pen-and-paper neuropsychological tests. Tests will also be carried out 
to ascertain if there is a significant difference between the strength of these 
correlations. 
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8 Methods 
8.1 Recruitment 
 
A total of 18 participants with MS were recruited through advertising on 
websites and social media accounts specifically for people with MS: www.MS-
UK.org and https://Shift.MS. MS Therapy Centres in and around London were 
also contacted for support with recruitment. MS Therapy Centres are third 
sector charity organisations which provide non-pharmacological therapies, 
such as physiotherapy and oxygen therapy, to members. Some MS Therapy 
Centres were also able to provide a room for testing to take place on their 
premises.  
MS Therapy Centre staff were asked to either directly approach 
members who they thought might be eligible or to put up a poster in a suitable 
location if they felt uncomfortable or unable to directly approach service users. 
Advertising also went out in Therapy Centres newsletters or through their 
social media platforms as appropriate. 
A summary of the inclusion and exclusion criteria were given to centres 
to help them identify suitable participants, as well as adverts which could be 
displayed on a noticeboard.  
If service users were approached by a member of staff at the charity, 
their contact details were given to the researcher with their consent. They 
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were then emailed a copy of the consent form and a time was scheduled for 
an eligibility check over the telephone 
24 participants were recruited to the healthy control group (HC). HC 
participants were recruited through word of mouth. Several community groups 
and places of work were approached for support with advertising the study, 
however all participants in the healthy control group were personally known to 
the researchers or were referred by friends. 
Testing took place in a suitable room at an MS Centre, on Royal 
Holloway premises (both the Egham campus and Bedford Square) or in the 
Royal Holloway rooms at Senate House in Central London. 
8.2 Inclusion and Exclusion Criteria 
Inclusion criteria for the both groups were as follows: age between 18 
and 65, no historic or current significant mental health difficulties, no 
sensorimotor difficulties that could impact the interface with the JEF©. For the 
MS group participants also needed a diagnosis of RRMS, no relapse in the 
last 6 weeks and no significant changes in medication. The RRMS subtype 
was chosen as it is the most common subtype of MS. It was decided not to 
include people with Secondary or Primary Progressive MS as research has 
shown that the presentation of the progressive subtypes may have a different 
aetiology which could have resulted in confounding factors. The age group 
18-65 was chosen to reflect the age range of most employed people.  
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8.3 Sample Size 
Previous studies using the JEF© have not detailed power calculations in 
their reports. However, previous JEF© studies which have used a between 
groups design have found that comparisons of 19 people in both the clinical 
and control group, have been sufficient to show a significant difference in 
performance (Denmark et al., 2017).  
Traditional pen and paper neuropsychological assessments usually 
show a large effect size for the difference in performance between people with 
MS and healthy controls. For example, d = 1.1 for the Symbol Digit Modalities 
Test (Benedict et al., 2016) and d = 0.9 for the California Verbal Learning 
Test, second edition (Parmenter, Testa, Schretlen, Weinstock-Guttman, & 
Benedict, 2010). It was therefore anticipated that there would be a large effect 
size for the comparisons carried out in this project. 
An independent t-test was used to analyse the data in order to 
investigate the first hypothesis, that there is a significant difference in 
performance on the JEF© for people with MS. A priori power calculations 
were carried out to establish the number of participants needed to achieve a 
large effect size. A minimum of 26 participants would need to be recruited to 
each group to achieve a power of 0.8 and a large effect size of d = 0.8. 
A Fisher’s r to z transformation was carried out where necessary to 
investigate the second hypothesis, that the results of the JEF© will be more 
strongly correlated to employment performance. A priori power calculations 
were also carried out to ascertain the number of participants needed to have a 
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power of 0.8 and a large effect size for this analysis. 66 participants would 
need to be recruited to each group in order to have a large effect size of d = 
0.5 and a power of 0.8.  
These power calculations informed the decision to attempt to recruit 132 
participants to each group in order to have a large effect size and sufficient 
power for both analyses. 
Ethical approval for this study was obtained from the Royal Holloway 
Ethics Committee. 
 
8.4 Materials 
The neuropsychological and psychological measures used in this study 
were chosen because they have been well validated for use within the MS 
population. A number of neuropsychological tests were chosen in order to 
have as comprehensive an assessment of executive functions as possible. 
8.4.1 The JEF© 
The JEF© is a non-immersive, virtual reality test which takes place in an 
office environment. The JEF© assesses the following cognitive constructs: 
planning, prioritisation, selective thinking, creative thinking, adaptive thinking, 
multitasking, time-based prospective memory (TBPM), action-based 
prospective memory (ABPM) and event-based prospective memory (EBPM). 
A  Total Score based on the averages of the other constructs can also be 
calculated.  (Denmark et al., 2017; Jansari et al., 2014; Jansari, Agnew, 
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Akesson, & Murphy, 2004; Jansari et al., 2013; Montgomery, Ashmore, & 
Jansari, 2011; Montgomery et al., 2010; Montgomery, Seddon, Fisk, Mruphy, 
& Jansari, 2012; Soar et al., 2016).  
The participant is asked to imagine that it is their first day as a new 
member of staff in the office. Since the manager is unable to meet them 
personally, they have left a list of instructions for what to do on their first day. 
The main task is to arrange the office so that it is ready for a meeting which is 
due to take place, however there are some other unexpected tasks that the 
participant must attend to. The participant is not given any cues for how to go 
about completing their tasks.  
There are three areas which the participant can navigate between - the 
main meeting room, a side office and a corridor. In the meeting room there 
are objects which are necessary for the participant to be able to complete the 
tasks, as well as other everyday items there to create a sense of realism.  
See figures 2 and 3 for screenshots of the JEF©. 
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Figure 2: Screenshot of the JEF© Meeting Room (taken from Denmark et al., 2017) 
 
 
 
Figure 3: Screenshot of the JEF© office (taken from Denmark et al., 2017)  
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8.4.2 Traditional Neuropsychological Battery 
8.4.2.1 Test of Premorbid Function (TOPF). 
Healthy controls and participants with MS were matched according to 
age, sex and premorbid IQ to avoid an effect of confounding variables. As 
such, participants were asked to complete the TOPF to have an estimate of 
premorbid IQ.  
The TOPF requires participants to read words which have atypical 
grapheme to phoneme translations. The TOPF is well correlated with full 
scale IQ as measured by the Wechsler Adult Intelligence Scale, Fourth 
Edition, r = 0.7 (Berg, Durant, Banks, & Miller, 2016).  
 
8.4.2.2 The Behavioural Assessment of the Dysexecutive 
Syndrome (BADS). 
The BADS is an ecologically valid battery which assesses planning, 
novel problem solving, multitasking, temporal awareness and cognitive 
flexibility (Norris & Tate, 2000; Wilson, Evans, Emslie, Alderman, & Burgess, 
1998). Since one of the advantages of the JEF© is its ecological validity, it 
was decided to compare it to existing neuropsychological tests which are also 
known for being ecologically valid. The subtests of the BADS have been 
shown to be moderately correlated to other measures of executive function 
and have a Cronbach’s alpha of 0.60 for the total score (Strauss, Sherman, & 
Spreen, 2006). Furthermore, the BADS has been used successfully in other 
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studies which have assessed executive function in this population  (Grech et 
al., 2017b; Honan, Brown, & Batchelor, 2015).  
The BADS is comprised of six tests: The Rule Shift Cards Task, The 
Action Program Test, Key Search, Zoo Maps, Temporal Judgement and 
Modified Six Elements. For this study, only Key Search and Zoo Maps were 
administered in order to keep the battery to a reasonable length of time. 
These particular subtests were chosen as both use real world scenarios to 
assess executive function, which is similar to the premise of the JEF©. 
Together these subtests assess planning, problem solving and self-monitoring 
abilities (Norris & Tate, 2000).  
For the Key Search test, the participant is asked to imagine that they 
have lost their keys in a field represented by a 100mm square drawn on a 
piece of A4 paper. The participant is asked to draw a line from a black dot 
located outside the square to indicate how they would walk around the field to 
ensure that they find their keys. 
The Zoo Maps test has two parts to it. In the first, high cognitive demand 
version, participants are given the map of a zoo and asked to draw which 
route they would take in order to successfully visit designated areas, whilst 
following specific rules about which paths they can use. In the second version, 
participants are simply required to follow a list of instructions in order to visit 
designated areas of the zoo. 
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8.4.2.3 Verbal fluency task. 
This task assesses semantic fluency and is a test of executive function 
as well as language. Participants are asked to list as many words as they can 
which are part of the same semantic group in 90 seconds (Henry & Beatty, 
2006). There is a high level of internal reliability for verbal fluency tests, r = 
0.83, as well as moderate levels of validity for different categories r = 0.66-
0.77 (Strauss et al., 2006). 
 
8.4.3 Cognitive Status Test 
8.4.3.1 Brief International Cognitive Assessment for Multiple 
Sclerosis (BICAMS). 
The BICAMS is a battery created to provide clinicians a brief cognitive 
assessment for people with MS which is more sensitive than screening 
questionnaires, yet does not require specialist expertise to administer 
(Langdon et al., 2012). It is comprised of the California Verbal Learning Test 
(Second Edition) (trials 1-5) (CVLT-II), which measures verbal memory, The 
Symbol Digit Modalities Test (oral version) (SDMT), which measures 
processing speed, and the Brief Visuospatial Memory Test – Revised (BVMT-
R) (trials 1-3), which assesses visuospatial memory. The BICAMS has 14 
validations already published and is fast becoming the international gold 
standard for assessing cognition in MS. 
In the SDMT, the participant is given a coding table which has numbers 
that are associated with symbols. The participant is also given a table which 
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has a series of symbols without their corresponding numbers. The task 
requires the participant to say which number matches the symbol as quickly 
as possible within a 90 second time limit. 
For the CVLT-II, the participant is asked to memorise a list of 16 words 
read by the examiner. The participant is then asked to immediately recall as 
many words as possible, in any order, from the list. The participant is given 
five trials and asked to recall words even if they have been said in previous 
trials. The examiner reads the words out in the same order each time. 
For the BVMT-R, the participant is presented with a stimulus which 
contains a 2 x 3 arrangement of abstract geometrical shapes. The participant 
is allowed to look at the stimulus for ten seconds before being asked to draw 
the correct shape in the correct position. This is carried out a total of three 
times. 
 
8.4.4 Psychological Measures 
8.4.4.1 COPE Inventory. 
The dispositional version of the COPE Inventory is a multidimensional 
questionnaire about coping styles which assesses the different ways in which 
people respond to stress (Carver et al., 1989). This is a 52-item, self-report 
questionnaire. Responses are measured on a 4-point Likert-scale with 
responses ranging from “I usually don’t do this at all” to “I usually do this a lot”. 
It has previously been used to assess coping styles in the MS population.  
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The authors of the questionnaire did not group the 15 scales into 
aggregates or composites such as “adaptive” or “maladaptive”. However other 
studies have created their own subscales “active”, “avoidant” and a 
combination of the two. This study will use the subscales used in previous 
research which showed a relationship between executive functions and 
avoidant coping strategies in the MS population (Grech et al., 2017b; 
Rabinowitz & Arnett, 2009).  
Maladaptive coping strategies therefore considered to be: denial, mental 
disengagement and behavioural disengagement. Adaptive coping strategies 
are: active coping, planning and suppression of other activities. Since 
participants can score highly on both the adaptive and maladaptive coping 
scales, a third composite scale will be used to look at overall coping. This is 
calculated by subtracting the z score for maladaptive coping from the z score 
for adaptive coping.  
The questionnaire has good internal validity, with an average Cronbach’s 
alpha of 0.79 (Measurement Instrument Database for the Social Sciences, 
n.d.). 
 
8.4.4.2 Hospital Anxiety and Depression Scale (HADS). 
As depression and anxiety are commonly reported by people with MS, it 
is necessary to ensure that this is not a confounding variable in this study. 
Participants will therefore complete the Hospital Anxiety and Depression 
Scale (HADS) (Zigmond & Snaith, 1983). This is a 14-item questionnaire 
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which uses a 4-point Likert scale for its responses. The HADS has been 
reported to have moderate to strong ratings of validity for the depression and 
anxiety subscales, r = 0.6 -0.8 (Bjelland, Dahl, Haug, & Neckelmann, 2002). It 
has been validated for use within the MS population and is regularly used as a 
screening questionnaire in clinics (Honarmand & Feinstein, 2009).  
 
8.4.4.3 Fatigue Severity Scale (FSS). 
As fatigue is a common symptom experienced by people with MS it is 
necessary to confirm that it is not a significant confounding factor for this 
study. Participants will therefore be asked to complete the Fatigue Severity 
Scale (FSS) (Krupp et al., 1989). This is a 9-item questionnaire asking 
participants to rate their experience of fatigue over the last week. It has good 
validity, r >0.5 and moderate reliability, ICC > 0.6 (Learmonth et al., 2013).  
 
8.4.5 Employment Measures 
As there are many reasons why PwMS may decide to leave their job, it 
is important that the questionnaires used to investigate employment 
performance also reflect this. The following self-report questionnaires were 
chosen as together they cover a number of socioeconomic, environmental 
and disease related factors which can contribute to poor workplace 
performance and ultimately unemployment.  
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8.4.5.1 Multiple Sclerosis Work Difficulties Questionnaire 
(MSWDQ). 
This self-report questionnaire consists of 50 items answered on a 5-point 
Likert scale and is designed to cover work difficulties experienced by people 
with MS. It has good internal validity and reliability and has been shown to 
account for up to 40% of the variance in reduced hours of employment since 
diagnosis including expectations about leaving work, expectations of being 
able to reduce one’s working hours and expectations about having to change 
jobs (Honan et al., 2012). 
 
8.4.5.2 Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-
Job). 
This self-report questionnaire consists of 42-items and was designed to 
measure the impact of MS on workplace tasks using a 5-point Likert scale. 
The questionnaire measures six scales: tactile perception and fine movement, 
fatigue-related mental functions and symptoms, movement and fatigue-related 
body functions, psychological and relational aspects, time and organization 
flexibility in the workplace, company’s attitudes and policies and an overall 
score (Schiavolin et al., 2016).  
The questionnaire has a Cronbach’s alpha of 0.86 and has moderate to 
strong correlations to other measures of disability and quality of life for people 
with MS (Raggi et al., 2015). 
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8.5 Procedure  
The neuropsychological tests were administered before the 
questionnaires to reduce the impact of testing fatigue on performance. 
Participants were asked to complete the neuropsychological tests in the 
following order: the JEF©, the TOPF, the BICAMS, Key Search and Zoo Maps 
from the BADS and the verbal fluency test. 
The JEF© software was run on a laptop with the 3D state software. 
Participants were administered the JEF© and the traditional, pen-and-paper 
neuropsychological test battery according to their respective administration 
manuals. Participants were given time to practise using the mouse to press 
the arrows on the screen which control movement and to pick up and move 
items within the JEF©. 
Participants were able to ask for clarification as appropriate. For the 
JEF© in particular, clarification was given about how to use the mechanics of 
the system (for example, moving between rooms and picking up objects), 
however no further information about how to go about completing the tasks 
was provided.  
Data collection was completed by as follows: 18 MS and 12 HC data 
collected by Laura Clemens (author), 5 HC data collected by Dr Gurpreet 
Reen (postdoctoral researcher, assisting) and 7 HC data collected by Zoe 
Mason (undergraduate psychology student, assisting). Both assistants 
received instruction and training in how to administer and score the 
neuropsychological tests from the author.    
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9 Results 
 
All neuropsychological tests were scored according to their 
administration manuals. Since scaled scores cannot be calculated for the 
BADS subtests, raw scores for neuropsychological tests have been used 
throughout. On all neuropsychological tests, higher scores reflect lower levels 
of impairment. On employment, mood and fatigue questionnaires, higher 
scores reflect a greater level of difficulties. Standard deviations are presented 
in parentheses in tables. With the exception of the correlations between 
composite variables (table 10), all variables are analysed by group, i.e MS 
and HC. 
All data were checked for normality and parametric tests were used 
where possible. Data were considered normally distributed if Z scores for 
skew and kurtosis were non-significant at p ≤ 0.01. 
The mean and standard deviation of scores from the HC group from this 
study were used for the calculation of Z scores for any variable that was 
standardised in this manner. 
As this is an exploratory study with a small sample size, a less 
conservative p-value of p ≤ 0.05 was used despite multiple analyses being 
conducted.  
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9.1 Group Demographics 
A total of 42 participants were recruited for this study - 18 participants with 
MS and 24 HCs. A summary of demographic data can be found in Table 5.  
Table 5: Demographic Information (means and standard deviations where appropriate) 
 MS HC 
Total number 
(Women : Men) 
18  
(14 : 4) 
24  
(13 : 11) 
Age (years) 45.33 (9.46) 44.41 (9.26) 
Years of Education  15.56 (2.89) 16.29 (2.98) 
Estimated Premorbid IQ (TOPF) 104.56 (10.98) 105.60 (10.79) 
Years Post Diagnosis  8.33 (5.89) N/A 
Note. *p < 0.05, **p = 0.01, ***p < 0.001 
 
 
ANOVAs were carried out to determine if there were significant 
differences in the demographics of the two groups. The ANOVAs found that 
there was no significant difference between groups on age (p = 0.78), years of 
education (p = 0.43) or premorbid IQ (p = 0.76).  
There were more women than men in both groups, however this reflects 
the gender demographics of people with RRMS. A Chi-Square analysis found 
that there were no significant differences in gender between the groups (p = 
0.11). 15 people in the MS group were ambulant, two people walked using 
crutches for aids and one person required the use of a self-propelled 
wheelchair. 
All control participants except one person were in some form of 
employment. The unemployed participant had last been in work 4 years ago 
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and took voluntary early retirement. All participants in the MS group were 
employed or involved in some sort of voluntary work. 
 
9.2 Disease-Related Variables 
Table 6: Means and Standard Deviations of MS Related Disease and Psychological 
Variables 
 MS HC 
HADS: depression*** 6.22 (4.43) 2.33 (2.63) 
HADS: anxiety 7.22 (5.56) 5.08 (3.41) 
FSS** 4.81 (1.85) 3.67 (1.72) 
Note. *p < 0.05, **p = 0.01, ***p < 0.001 
 
 
Means and standard deviations for scores on the HADS questionnaire 
and the FSS can be found in Table 6. Independent t-tests were carried out 
and separate variance estimates were used as homogeneity of variance 
estimates were not met (HADS anxiety: F = 8.54, p = 0.01, FSS: F = 9.46, p = 
0.004). T-tests found that there was no significant difference between the 
groups on measures of anxiety, however there was a significant difference 
between groups on fatigue (t(24.11) = 4.18, p < 0.001).  
HC scores for HADS depression were significantly positively skewed and 
a Mann-Whitney U test was therefore carried out. This showed that PwMS 
were significantly more depressed than the HC group (U = 90.50, p = 0.01).  
Although fatigue and low mood could be considered confounding factors, 
it was decided not to covary these variables as fatigue and low mood are 
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physical or neuropsychiatric symptoms of MS (Murphy et al., 2017; Wicks et 
al., 2016). Furthermore, studies have found that subjective reports of 
cognition in MS are mediated by depression and other psychological factors 
which is not the case for objective measurements (Bruce et al., 2010; Van der 
Hiele et al., 2012).  
 
9.3 Neuropsychological Battery Test Scores 
9.3.1 The JEF© 
Table 7: Means and Standard Deviations of JEF© Scores 
 MS HC 
Total Score* 58.40 (14.20) 68.80 (14.90) 
Planning  56.50 (25.70) 69.40 (28.80) 
Prioritisation  81.90 (24.00) 88.50 (19.50) 
Selective-Thinking 70.80 (32.40) 77.10 (28.50) 
Creative Thinking* 41.70 (30.90) 64.60 (32.90) 
Adaptive-Thinking 51.40 (27.70) 58.30 (31.90) 
Action-Based Prospective Memory* 30.60 (31.60) 49.00 (23.90) 
Event-Based Prospective Memory 75.00 (19.20) 80.20 (24.40) 
Time-Based Prospective Memory 59.70 (34.00) 63.50 (28.50) 
Note: All JEF© scores are percentages 
Total score is the mean of the JEF© subtests 
*p < 0.05, **p = 0.01, ***p < 0.001 
 
 
Means and standard deviations for the JEF© subscales and JEF© Total 
Score can be found in Table 7. A graphical representation of this data can be 
found in Appendix II. HC scores for the prioritisation subscale on the JEF© 
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were significantly negatively skewed. A Log10 transformation on reflected 
scores was carried out to achieve a normal distribution for the use of 
parametric tests.  
A t-test found that the HC group had significantly better JEF© Total 
Scores than the MS group (t(40) = -2.26, p = 0.03).  
ANOVAs were carried out on JEF© subscale scores to accommodate 
testing multiple dependent variables. Homogeneity of variance was not met 
for the event-based prospective memory subscale (F = 4.29, p = 0.05) so 
separate variance estimates were used and a t-test conducted. Out of the 
eight subscales, significant differences were only seen on the creative-
thinking subscale (F(1, 40) = 5.25, p = 0.03) and action-based prospective 
memory subscale (F(1, 40) = 5.07, p = 0.03). 
The JEF© therefore appears to be able to discriminate between the HC 
and MS population and is sensitive to deficits as proposed in the first 
hypothesis. 
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9.3.2 Executive Function and BICAMS 
 
Table 8: Means and Standard Deviations of Executive Function and BICAMS Tests 
Test MS HC 
BADS: Zoo Maps* 10.56 (3.87) 13.83 (2.85) 
BADS: Key Search 13.67 (2.77) 12.58 (2.83) 
Semantic Fluency 25.67 (6.20) 22.92 (6.23) 
BICAMS: SDMT 52.83 (12.59) 51.79 (12.45) 
BICAMS: BVMT-R 22.44 (4.68) 24.38 (5.72) 
BICAMS: CVLT-II 53.11 (12.66) 49.41 (10.27) 
Note. *p < 0.05, **p = 0.01, ***p < 0.001 
 
 
The descriptive statistics for the traditional neuropsychological test 
battery and the BICAMS can be found in Table 8 above. With the exception of 
Zoo Maps, ANOVAs found that there were no significant group differences on 
the executive function test battery, or the BICAMS (Zoo Maps: F(1, 40) = 
10.01, p = 0.003). 
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9.3.3 Employment and COPE Questionnaires 
Table 9: Means and Standard Deviations of Employment and COPE Questionnaires 
Questionnaire MS HC 
MSQ-Job*** 87.78 (32.68) 57.86 (18.26) 
MSWDQ*** 119.83 (49.05) 69.58 (15.83) 
Adaptive Coping 36.22 (6.38) 34.13 (5.24) 
Maladaptive Coping* 20.06 (4.52) 23.83 (6.40) 
Total Coping* 1.00 (1.25) 0.00 (1.62) 
Note. Total Coping scores are Z scores 
*p < 0.05, **p = 0.01, ***p < 0.001 
 
 
The means and standard deviations for the employment and coping 
questionnaires can be found in Table 9. Higher scores on the employment 
questionnaires represent greater levels of work difficulties. Maladaptive 
Coping and Adaptive Coping scales were created by combining the scores of 
specific scales on the COPE as outlined in previous studies (for example, 
Grech et al., 2017). Higher scores on the Adaptive and Maladaptive Coping 
scales represent greater use of these types of coping strategies.  
HC scores for the MSQ-Job were significantly positively skewed. A 
fractional transformation was carried out to achieve a normal distribution of 
data. A Total Coping Score was created by converting the Adaptive Coping 
and Maladaptive Scales to Z scores and subtracting the new standardised 
Maladaptive Coping score form the standardised Adaptive Coping score as 
outlined in previous studies. 
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An ANOVA was initially conducted on MSWDQ and MSQ-Job data. 
However, separate variance estimates needed to be used for MSWDQ data 
as homogeneity of variance assumptions were not met (F = 29.86, p < 0.001). 
Therefore, a separate t-test was carried out for this data. There were 
significant differences between groups on both employment questionnaires 
(F(1, 40) = 20.11, p < 0.001 and t(19.67) = 4.19, p < 0.001 for the MSWDQ 
and MSQ-Job respectively), with PwMS consistently reporting a greater 
number of work difficulties.  
There was no significant difference between groups on the Adaptive 
Coping scale (p = 0.25), however an ANOVA showed that the HC group used 
significantly fewer maladaptive coping strategies in comparison to the MS 
group (F(1, 40) = 4.56, p = 0.04). A t-test found that the MS group had better 
overall coping strategies (t(40) = 2.18, p = 0.04).  
PwMS scored higher on Total Coping- as this score reflects the 
combination of both maladaptive and adaptive coping styles, this may be 
explained by PwMS using fewer maladaptive coping strategies.  
 
9.4 Relationships between Executive Function, Employment 
and Coping 
A composite score for the traditional executive function tests was 
created by converting the raw scores of the individual subtests to Z scores 
which were then added together (Executive Function Index). A composite 
score for the employment tests was created in the same way (Employment 
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Index). Pearson’s correlations were carried out to assess the relationship 
between the Executive Function Index, Employment Index and Adaptive, 
Maladaptive and Total Coping scales. Pearson’s correlations were also 
carried out to establish if there was a relationship between the JEF© Total 
Score, Executive Function Index, Adaptive, Maladaptive and Total Coping 
Scales. Participants were not separated according to group for these 
correlations. The results of these correlations can be found in Table 10 below. 
Only significant relationships will be discussed further.  
 
Table 10: Correlations between JEF© and Executive Function Index and Coping 
Scales 
 JEF© Total 
Score (r) 
Executive Function 
Index (r) 
Fisher’s r to z 
ratio (z) 
Executive Function 
Index 
0.65*** - - 
Employment Index -0.32* -0.15 -0.8 
Maladaptive 
Coping 
-0.04 -0.18 0.63 
Adaptive Coping 0.32* 0.38** -0.3 
Total Coping 0.25 0.38** -0.64 
Note: N = 42 
*p < 0.05, **p = 0.01, ***p < 0.001 
 
 
 
There was a significant, moderate correlation between the JEF© Total 
Score and the Executive Function Index which suggests that the JEF© is able 
to measure and assess executive function. There was also a weak, but 
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significant negative correlation between the JEF© total score and 
Employment index. However, there was no significant relationship between 
the Executive Function Index and the Employment Index. A Fisher’s r to z 
calculation found that there was no significant difference in the strength of 
these correlations. Therefore, it is not possible to accept the second 
hypothesis that the JEF© is more closely correlated to employment outcomes 
in comparison to the traditional neuropsychological tests used. 
There were weak, significant correlations between both the JEF© total 
score and the Executive Index and the Adaptive Coping Scale. A Fisher’s r to 
z transformation was carried out to ascertain if there was a significant 
difference in the strength of any of the correlations including coping variables, 
however this returned a non-significant result for all variables. It is therefore 
not possible to accept the third hypothesis, that the scores from the JEF© 
would be more strongly correlated to coping styles in comparison to the 
traditional neuropsychological tests.  
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10 Discussion 
10.1 Summary of Relevant Findings 
A cross-sectional study was conducted to investigate whether the JEF© 
device is able to detect difficulties in executive function in the MS population 
and to find out how this compared to traditional, pencil and paper methods of 
executive function.  
As the JEF© aims to be an ecologically valid assessment of cognition it 
was also decided to see if there were relationships between the scores of the 
JEF©, employment outcomes and coping styles – both of which have been 
shown to be related to executive function within the MS population (Grech et 
al., 2017b; Honarmand et al., 2011; Jansari et al., 2014; Morse et al., 2013; 
Van der Hiele et al., 2015).  
18 participants with MS and 24 healthy controls were recruited who were 
matched on all demographic variables and anxiety but not low mood or fatigue 
which are common symptoms of MS. There were no significant differences 
between the MS and HC group on BICAMS measures which assess cognitive 
domains frequently affected in MS. This may be due to the recruitment criteria 
and/or sample size of the study.  
PwMS who are employed frequently out-perform their unemployed peers 
on measures of cognition (see section 5.1, p. 70 for further details). It is 
therefore possible that the sample of this study represents a selection of 
PwMS who are less severely impaired by the condition by virtue of their being 
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in work. Nevertheless, PwMS who are employed often perform worse in 
cognitive testing than a healthy control population. It may be that the small 
sample size of this study meant that there was insufficient power to detect this 
difference.  
 
10.1.1 Hypothesis 1  
The first hypothesis stated that the JEF© would be sensitive to deficits in 
executive function in the MS population. Although there were no significant 
differences between groups on several of the JEF© subscales (namely: 
planning, prioritisation, selective-thinking, adaptive-thinking, event-based 
prospective memory and time-based prospective memory), there were 
significant between group differences on JEF© total score, creative thinking 
and action-based prospective memory. The only traditional executive function 
test which showed differences between the HC and MS group was Zoo Maps. 
This may be explained by the test already being considered to be ecologically 
valid (Wilson et al., 1996).  
The JEF© Total Score was also correlated with the composite score of 
Executive Index. This found that there was a moderate, positive significant 
relationship between the JEF© and existing executive function tests. This 
provides further evidence which suggests that the JEF© is indeed assessing 
executive function. 
Taken together, these results would suggest that the JEF© is sensitive 
to executive functioning within the MS population as initially predicted.  
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10.1.2 Hypothesis 2 
The second hypothesis stated that the JEF© would be more strongly 
correlated to employment outcomes than traditional neuropsychology tests. 
Correlations between the composite Employment Index, the JEF© Total 
Score and the Executive Function Index were carried out.  
There was a weak, but significant negative correlation between the 
JEF© and the Employment Index where greater levels of work difficulty were 
associated with poorer total score on the JEF©. There was no significant 
relationship between the Executive Index and the Employment Index. Fisher’s 
r to z calculations were carried out to determine if there was a significant 
difference in the strengths of the correlations between the Employment Index 
composite and the JEF© total score or Executive Index composite and 
returned non-significant results. Therefore, the second hypothesis that the 
JEF© is more strongly correlated to employment outcomes than the existing 
executive function tests cannot be supported by the outcome of this study. 
Power calculations outlined in section 8.3 (p.91) indicated that 66 people in 
each group would be needed if there was a large effect size. Unfortunately, 
this was not achieved and the actual power for this analysis was 0.13. It is 
therefore unclear as to whether no difference in the strength of these 
correlations was found due to not having enough power or because there is 
no actual difference between the populations. 
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10.1.3 Hypothesis 3 
The third hypothesis stated that the results of the JEF© would be more 
strongly correlated to coping styles in comparison to existing 
neuropsychological tests. 
Correlations were carried out between the three coping subscales: 
Adaptive Coping, Maladaptive Coping and Total Coping, JEF© Total Score 
and the Executive Function Index.  
There were no significant correlations between Maladaptive Coping and 
JEF© Total Score and Executive Index. A significant, weak correlation was 
found between Total Coping and the Executive Index, but not between Total 
Coping score and the JEF© Total Score. There were significant, weak positive 
correlations between both the JEF© Total Scale and Executive Index and 
Adaptive Coping. A Fisher’s r to z transformation was carried out to assess 
whether there was a significant difference between these correlations, 
however none was found.  
The impact of having a small sample and subsequent power achieved 
cannot be discounted as a reason for not finding significant differences in the 
strength of these correlations. The power achieved for the Fisher’s r to z 
transformation the coping variables are as follows: for Maladaptive Coping, 
the power achieved was 0.10. The power achieved for Adaptive Coping was 
0.06. The power achieved for Total Coping was 0.10. 
Taken together, the results indicate that the JEF© Total Score is not 
significantly related to Maladaptive Coping Styles, or Total Coping. Although 
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the JEF© Total Score and traditional executive function battery are both 
significantly related to Adaptive Coping styles, results are inconclusive as to 
whether there is a significant difference in the strength of these correlations 
due to the low level of power achieved for the Fisher’s r to z transformation, 
therefore Hypothesis 3 cannot be accepted. 
 
10.2  Relationship to Existing Literature 
This study adds to the existing body of literature about the JEF© which shows 
that it is sensitive to deficits in executive function in clinical populations such 
as frontal lobe brain injury and acquired brain injury. It also adds to the 
evidence showing the JEF© to be capable of detecting deficits which may not 
be found in the performance on other traditional executive tests, such as the 
Stroop (Denmark et al., 2017; Jansari et al., 2014, 2013, Montgomery et al., 
2011, 2010; Soar et al., 2016). 
The results further highlight the need for the use of ecologically valid 
tests which also have a high level of experimental control for clinical and 
research settings (Chaytor & Schmitter-Edgecombe, 2003). This is one of the 
2 studies which compares data from the JEF© against subtests from the 
BADS, an ecological valid battery which is well used in clinical practice 
(Wilson et al., 1996). 
Reports of executive function (assessed on conventional tests) affecting 
employment are patchy in the MS population, with some studies finding 
significant differences between groups whilst others not finding any. These 
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results provide support to the theory that difficulties with executive function 
seen in MS are related to negative work events. Similar results have been 
found by Van der Hiele and colleagues (2015), Morse and colleagues (2013) 
and Honarmand’s group (2011).  
As previously mentioned, executive function is not a singular construct. 
Instead it is an umbrella term used to describe a series of complex cognitive 
abilities needed to successfully carry out goal-orientated behaviours (Miyake 
et al., 2000). It may therefore be necessary to ensure that these different 
subcomponents are adequately assessed in research make sure a thorough 
understanding of how executive function as a whole affects employment in 
this population. The JEF© is a more comprehensive assessment, evaluating 
many aspects of executive function. It takes approximately 40 minutes to 
complete, which is a similar length of time to the BADS, and therefore could 
be feasibly used in a clinical setting to assess several aspects of executive 
function in the same amount of time, or less, than a traditional executive 
function battery.  
An unexpected finding was that people in the Healthy Control group 
used more Maladaptive Coping strategies in comparison to the MS group. It is 
possible that PwMS who are able to remain in employment represent a 
subgroup who use more Adaptive Coping strategies in order to manage the 
difficulties that accompany their diagnosis, including difficulties with 
employment. On the other hand, healthy individuals who do not have to 
manage the stresses which come with a chronic health condition may be able 
to utilise more maladaptive coping strategies with less negative effects.  
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10.3 Limitations  
10.3.1 Neuropsychological Measures 
One of the limitations of this study is that only two subtests from the 
BADS were used rather than all six subtests. This meant that it was not 
possible to calculate scaled scores for the BADS as this requires the profile 
scores of all six subtests.  
This difficulty was side-stepped by using raw scores for all the tests 
rather than scaled scores. However, the subtest profile scores take into 
account the length of time taken to complete the task – successfully or 
otherwise. This means that whilst two people might both score the maximum 
number of raw score points on Zoo Maps and Key Search, they may have 
different profile scores. This subsequent profile score would reflect not just 
performance, but how effortful the individual may have found the task. 
Furthermore, using total profile scores would have meant that it would have 
been possible to calculate individual standard scores which would have 
accounted for age as well as effort.  
Although there were no significant differences in the mean ages of the 
two groups, it is worth noting that the youngest participant in the HC and MS 
group were 29 and 30 respectively, and the oldest participants were 55 and 
62. Despite obtaining the same profile score on the BADS, there could have 
been a difference of 10 standard points between the 29 year old and the 62 
year old participants (Burgess, Alderman, Evans, Emslie, & Wilson, 1998). 
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In addition, whilst the JEF© may simultaneously measure different 
components of executive function, the traditional neuropsychological 
measures used do not reflect the full range of executive functions. For 
example there is no test which assesses cognitive set-shifting or mental 
flexibility, such as the Sorting Task or Trail Making from the Delis Kaplan 
Executive Function System (DKEFS) (Delis, Kaplan, & Kramer, 2001).  
A more robust selection of tradition executive function measures which 
are able to produce age or standardised scores for comparison against the 
JEF© would improve this research. 
10.3.2 The JEF© 
One of the limitations of the JEF© is that it requires the participant to 
read out loud after the in-program timer has started. This is a particular 
problem as the participant needs to take note of a fire-alarm which sounds 5 
minutes into the task. On occasion, it was noticed by the administrator that 
people had not finished reading the list of instructions as required when this 
first alarm went off. There is a possibility that a person did not hear the alarm 
as they were speaking over the top of the noise. Depending on the individual’s 
reading speed, there may even be a possibility that they have not reached the 
instructions regarding the fire alarm and therefore ignored it. Conversely, 
people who are able to read aloud quickly may come to the end of this task 
ahead of time, thus allowing them more time to plan and proceed with the rest 
of the test.  
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There is, therefore, a potentially undesirable effect of reading speed on 
performance. An improvement may be to start the in-program timer after the 
participant has finished reading their list of tasks and instructions. This is 
similar to how Zoo Maps is administered, where the participant reads aloud 
the instructions and receives clarification before timing begins. 
Ceiling effects on the JEF© are another limitation of the test which 
needs to be considered. On three subtests, prioritisation, selection and event-
based prospective memory, over 50% of participants in the control group 
managed to score 100%. Similarly, 55.6% of people in the MS group were 
also able to score full marks on the prioritisation subscale. It is therefore 
difficult to know whether ability on these subscales has been accurately 
measured (Salkind, Frey, Dougherty, Rasmussen Teasdale, & Hill-
Kapturczak, 2010).  
 
10.3.3 Sample and Recruitment 
As previously mentioned, it was not possible to recruit the number of 
participants needed to have a power of 0.8. Whilst previous studies using the 
JEF© have been able to see an effect similar to those reported in this study 
(Denmark et al., 2017; Jansari et al., 2014; Montgomery et al., 2012), it is 
necessary to mention that this study was under powered, particularly for the 
analyses needed to investigate Hypothesis 3. However, the effect size was 
sufficient to demonstrate a difference on Total JEF© Score between groups. 
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It is important to consider how representative the sample in this study in 
comparison to the general population. Firstly, participants who took part, 
primarily lived in London and the South East which could have resulted in a 
more biased demographic. 
Secondly, the MS group was comprised solely of people who reported 
having RRMS, therefore leaving out two thirds of the MS subtypes. Although 
RRMS is the most common subtype of MS, excluding the other two main 
subtypes means that the disease as a whole is not represented in this study. 
On one hand, this is an exploratory pilot study and it is necessary to reduce 
the impact of differences in disease and demographic variables on the results. 
There is evidence that the cognitive and disease profiles of the progressive 
subtypes of MS are significantly different to those seen in RRMS which 
supports the decision to exclude two subtypes (Dickens et al., 2014; Ntoskou 
et al., 2018; Ruet, Deloire, Charre-Morin, Hamel, & Brochet, 2013). However, 
it is possible that the outcome would not be the same if people with SPMS 
and PRMS were included and therefore results should not be generalised to 
the other two subgroups.  
Furthermore, given that this is a cross-sectional study, it is not possible 
to determine causality and the possibility of employment difficulties leading to 
cognitive impairment cannot be excluded. It should also be mentioned that the 
effects of fatigue and depression on cognitive performance cannot be 
eliminated as confounding factors in this study.  
Participants with MS were recruited via MS charity websites and through 
advertising at MS Therapy Centres. MS Therapy Centres are standalone 
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charity organisations which provide complementary therapies such as 
physiotherapy, oxygen therapy and counselling. They also allow people with 
MS to access peer support. It is not mandatory for people with MS to access 
these centres and they may not be as easily accessible as more local NHS 
MS clinics.  
Recruiting from MS websites and their associated social media platforms 
also means that adverts may not have reached people who are less 
technologically literate or choose not to use social media for various reasons. 
Therefore, the population from which the sample was taken may not be 
representative of the wider MS population.  
Since participants were not recruited from the NHS, it was not possible 
to confirm that they had a diagnosis of clinically definite RRMS using 
neurology reports or to have access to health records to confirm that they did 
not have other conditions which may have excluded them from testing, 
despite having checked this verbally with participants during screening. 
In addition, information regarding employment difficulties was gained 
through self-report questionnaires only, and there were no external or 
objective reports of performance at work. 
Another limitation is that no tests were carried out to assess 
sensorimotor difficulties, such as  visual acuity or motor functioning which are 
areas that are frequently affected by MS (Wicks et al., 2016). These are also 
problems which could affect using the JEF© in a practical manner as it 
requires sustained viewing of a computer screen and the use of a mouse or 
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mousepad. However, the author has considerable experience as a clinician 
and researcher and closely monitored the level of sensorimotor difficulties to 
minimise these confounds. 
 
10.4 Clinical and Research Implications 
This study was an exploratory study which aimed to pilot new technology 
in this clinical group. It has provided further support to the theory that 
cognitive difficulties, including executive dysfunction, negatively impact 
employment outcomes for people with MS. The results of the employment 
questionnaires also demonstrate that people with MS report experiencing a 
greater number of work difficulties in comparison to the general population. It 
adds weight to the need to continue to research this area so that people with 
MS who want work can continue to do so. Nevertheless, there were some 
difficulties which arose from the design of the study and future studies should 
aim to mitigate these as much as possible in order to ensure that difficulties 
observed are due to executive dysfunction and not unfamiliarity with the JEF© 
program and its interface. 
Although fatigue over the preceding week had been measured, state 
fatigue was not taken in to account on the day. Nor were participants formally 
asked about how anxious they felt in using a new software programme, 
although participants were provided with appropriate reassurance if they 
expressed any anxiety at the thought of being assessed or using the 
programme. Replication of this study should include measurement of state 
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fatigue and anxiety. This could be achieved by asking participants to 
subjectively rate how fatigued they felt on the day and how anxious they felt at 
using the test. If participants rated themselves as being highly anxious they 
could have been invited to do some breathing exercises or progressive 
muscle relaxation until they could report a reduction in how anxious they felt.  
Future research should also include a way to ensure that participants 
have sufficient practice so that they are competent and well adapted to the 
JEF© program to ensure that difficulties which arise are due to executive 
dysfunction and not problems with using new software with an unfamiliar 
interface. 
Subsequent research could focus on replicating this study with a larger 
sample size, a more extensive battery of ecologically valid executive function 
tests, and tests which are less ecologically valid, but which assess other 
subcomponents of executive function. Objective reports of work performance 
could also be gathered from a participant’s colleague or employer to add to 
the self-reported information from employment questionnaires. 
Following this, the study could be broadened by extending the inclusion 
criteria to allow for all subtypes of MS. Results could be analysed both by 
individual subtypes as well as a mixed sample. Recruiting from multiple NHS 
sites as well as from third sector agencies would access more people who 
might be more representative of the MS population. As well as allowing for 
confirmation of MS diagnosis, it would also be an opportunity to investigate 
whether the JEF© can be used effectively in a clinical setting.  
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There was anecdotal feedback from participants stating they felt that the 
difficulties they faced completing tasks during the JEF© test reflected real life 
difficulties they experienced at work and at home. It would be interesting to 
see if this is shared experience. A mixed methods qualitative and quantitative 
approach could be used to investigate this, both within the MS community, 
and other clinical populations. Due to potential difficulties with insight into 
deficits, it may be helpful to have a reliable informant present when the 
participant is completing the JEF© so they can also provide feedback. 
As the results show that executive function difficulties are related to 
negative work outcomes, it may be beneficial for psychologists to include 
executive function tests, particularly ecologically valid tests such as the 
BADS, as part of their assessment to see whether there are any difficulties in 
this domain. This would allow clinicians to be able make recommendations 
regarding work accommodations that could be implemented.  
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11 Conclusion 
This study found that the JEF© is capable of assessing executive 
function for people with RRMS and is able to discriminate between them and 
a healthy control population. This was also the case for the Zoo Maps test, but 
none of the other tests of executive function.  
There was a significant difference in reported work difficulties 
experienced, with people with MS reporting a greater number of problems in 
comparison to the control sample.  
There was a correlation between the work difficulties experienced and 
scores on the JEF©, which suggests that the executive function difficulties 
detected are relate to real world consequences.  
Whilst there were significant correlation between the Total JEF© score, 
the Executive Index and adaptive coping, there was no significant difference 
in the strength of these correlations.  
The utility of ecologically valid tests of executive function are highlighted 
by the results of this study. Further research could focus on replicating the 
results with a larger sample size, as well as a mixed group of PwMS and a 
more robust traditional executive function battery. 
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12 Paper 3: Integration, Dissemination and Impact 
12.1 Integration 
This thesis has a strong focus on how cognition is linked to work 
difficulties in Multiple Sclerosis (MS). The systematic review was chosen to 
give a broader overview and understanding of the relationship between 
cognition and employment within this population. The findings of the review 
were very consistent. People with MS (PwMS) who were unemployed 
performed poorly in cognitive tests in a number of domains in comparison to 
PwMS who managed to remain in some form of employment. In addition, 
PwMS who were employed were still out performed on these tests by healthy 
control groups.  
Significant group differences were not seen in every cognitive domain, 
for example attention-concentration. However, deficits were seen in several 
cognitive domains, such as delayed memory recall, immediate memory recall 
and information processing speed as well as executive function. However, a 
significant impact of executive dysfunction on negative work events or 
unemployment was not consistently found amongst the studies which 
assessed this area. A relationship between the executive functions of idea 
generation and set shifting and employment was seen. 
The inconsistent relationship between outcome on traditional executive 
function tests and employment served as further basis for the empirical study, 
which could add to the body of literature about the role of executive function in 
129 
 
employment. The empirical study, using the Jansari Assessment of Executive 
Function (JEF©), also built on the literature by including more ecologically 
valid measures of executive function - only one study in the systematic review 
included ecologically valid measures of executive function, namely Zoo Maps 
and the Modified Six Elements Test (Morse et al., 2013). 
The results of the empirical study were in line with the results of the 
systematic review. Namely, that there is a relationship between executive 
function as measured by the JEF© and negative work events. Whilst there 
was a between group difference on the JEF© Total Score, there was also a 
between group difference seen on the subscales of Creative thinking and 
Event-Based Prospective Memory. It is possible that differences in these 
areas are similar to the differences found in set shifting and idea generation in 
the systematic review.  
Creative thinking involves finding solutions to problems using 
unspecified methods, whilst Action-Based Prospective Memory requires the 
participant to remember to take action after a specific stimulus. It is possible 
that these subscales are analogous to idea generation and set shifting. 
Creative thinking on the JEF© involves unprompted idea generation, whilst 
Action-Based Prospective Memory requires cognitive flexibility in order to 
move between tasks successfully.  
The results of the systematic review and empirical study, therefore 
provide a coherent narrative regarding the relationship between cognitive 
impairment in MS and workplace difficulties and employment outcomes.  
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12.1.1 Challenges and Improvements 
Despite the successful outcome of the empirical study, its final design 
was not its original incarnation. The challenges and difficulties are described 
below, as well as potential improvements that could have been made. 
 
12.1.1.1 Test battery. 
It was initially hoped that a larger test battery, which included more 
ecological tests of executive function, would be administered. This would have 
included the remaining subtests from the Behavioural Assessment of 
Dysexecutive Syndrome Battery (BADS) – Rule Shift Cards Test, Temporal 
Awareness, Action Programming and The Modified Six Elements Test. It 
would have also used the Sorting Task from the DKEFS as an additional 
measure of cognitive flexibility and idea generation. However, this would have 
extended the battery to 2.5 hours which may have led some people to 
become fatigued. Given that fatigue is a symptom of MS, it was important to 
consider how and if people would manage a long battery of 
neuropsychological tests. It was therefore decided to reduce the test battery 
so that it could be completed in 2 hours which is typical of other studies 
assessing cognition in MS. 
In fact, it was frequently the case that whilst the healthy control 
population was able to complete the study in two hours, people with MS took 
longer - this may be due to difficulties with information processing speed seen 
in this population. In hindsight, a pilot version could have been carried out to 
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get a more accurate idea of how long the test battery would take and to get 
feedback from participants as to whether it was manageable or whether they 
felt fatigued by the process. I would also build in breaks between participants 
to provide a buffer in case a participant was particularly slow so that the next 
participant could be seen promptly. 
One way of overcoming the issue of fatigue might have been to conduct 
testing over two separate sessions. However, this would have required more 
time and was not feasible and within the scope of a Clinical Psychology 
research project. Furthermore, trying to access a population who are still in 
employment meant that it was difficult to find time the individual would be able 
to spare, unless self-employed or had flexible working hours. Whilst this was 
managed with a single 2-hour testing session, people may have been less 
willing to participate with a greater time commitment. 
The test battery did not include tests of visual and contrast acuity or tests 
of motor function which are areas often affected by MS, but which could also 
affect how an individual was able to use the JEF©. An improvement would be 
to include appropriate tests, such as the Nine-Hole Peg Test or the Snellen 
Test. The Nine-Hole Peg Test is a measure of arm and hand function where 
the individual is required to place nine pegs into holes as quickly as possible. 
It is frequently used for clinical and research purposes in the MS population 
and forms part of the Multiple Sclerosis Functional Composite measures 
(MSFC) (Fischer, Rudick, Cutter, & Reingold, 1999). The Snellen Visual 
Acuity test requires people to read a series of letters at a distance of 6m and 
is well used by opticians and ophthalmologists. In addition, the Multiple 
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Sclerosis Vision Test Battery could be used to assess contrast acuity 
(Bullimore, 2016).  
 
12.1.1.2 Recruitment. 
Recruiting from websites meant that there was no way to risk assess 
participants prior to meeting them and all testing needed to be carried out in a 
public space. For this reason, testing took place either at Senate House 
Library or Royal Holloway. However, not being able to have more flexible or 
local testing sites may have limited the level of interest that was generated.  
One participant mentioned that a friend with MS had wanted to take part 
but had been put off by the need to come into Central London. If it had been 
possible to recruit from the NHS as planned, MS participants would have 
been given the option to do the study at home as discussions could have 
taken place with their MS nurse or team regarding any risks they were aware 
of.  
On one hand, it is difficult to guarantee that a participant will have an 
environment that is suitable for testing, despite making explicit requests, as I 
have noticed doing cognitive testing in my clinical role, however offering the 
possibility of a home visit might have allowed more people to take part. Still, 
this would have not resolved the problem of having people who were from a 
specific geographical location.  
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12.1.1.3 The JEF©. 
12.1.1.3.1  Medical device status. 
The nature and use of the JEF© frequently posed a number of 
challenges for this project. Whilst applying for proportionate ethical review by 
HRA, it was brought to our attention that the JEF© was actually considered to 
be a medical device. The formal definition of a medical device is “an 
instrument, apparatus, appliance, material or other article, whether used alone 
or in combination, together with any software necessary for its proper 
application, which is intended by the manufacturer to be used for human 
beings for the purpose of diagnosis, prevention, monitoring, treatment or 
alleviation of disease” (“Medical Device Regulation 2002,” 2002). The creator 
of the JEF© reported never having encountered this problem in the past. 
Since the JEF© has no CE marking it was not eligible for proportionate review 
and full HRA and REC ethics was sought. This led to some delay with starting 
recruitment.  
Whilst the study went through HRA and REC review without issue, the 
NHS trust originally approached felt the study could not be considered “in-
house” despite involving a member of staff as a supervisor and that the JEF© 
would need to get a CE marking. It was eventually decided to recruit 
participants through MS Therapy Centres and Charities rather than through 
the NHS. The need to obtain CE marking for the JEF© for use in NHS setting 
was also brought to the attention of its creator. 
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12.1.1.3.2 Difficulties using the program. 
There were several difficulties noted in using the program. One of these 
is related to its interface and how people move around, pick up and put down 
objects in the system.  
Whilst many people were able to use the program without difficulty 
following the initial instructions, other people did struggle to use the interface. 
Since computer and technological literacy is not being assessed by the JEF©, 
it is important to have a design which is simple enough for an individual with 
little or no computer experience to use. However, the method of moving 
around, that is clicking directional arrows on the screen, is different to how 
people are currently accustomed to moving around in games or programs 
such as “Google Maps”. In these programs, people are able to use a “double-
click” function to move to where they want to go, and people often tried to do 
this on the JEF©. 
In addition, the left and right arrows serve to change the field of vision 
left and right, rather than moving the individual laterally in that direction. In 
effect, clicking the left and right arrow keys in the JEF© is similar to turning left 
and right on the spot in real life. Again, people found this challenging given 
that it is somewhat counter-intuitive to how we expect to use arrows to move 
around in other programmes and games. On two occasions, participants 
became “stuck” in the door and were unable to leave the office or move 
anywhere else. As this was early on during testing, it was possible for the 
programme to be restarted, however this would not have been feasible later in 
the assessment. 
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Similarly, the movement of objects in the JEF© is unlike how an 
individual would expect to move objects within a computer programme. 
Although, the individual is given instructions and specifically told not to “click 
and drag” objects, people frequently did this by accident and appeared to be 
having to inhibit well learnt responses. This posed further difficulties as 
objects sometimes “disappeared” when a participant accidently tried to drag it. 
This problem broke the illusion of the “semi-immersive” experience.  
Whilst this was not a problem if a non-essential item disappeared, it was 
more problematic if it was an item crucial for completing a task. For example, 
losing one of the virtual memos is of very little consequence as the participant 
has a hard copy on the table with more information on it than the virtual 
memo. However, losing either of the overhead projectors means that the 
participant is unable to either switch on the project or replace the broken one 
with the spare. When this happened, the assessor had to ask the participant 
what they were planning to do with the object. This also meant that the 
assessor had unintentionally indicated whether a particular item was 
important.  
One of the participants brought to my attention the fact that there are no 
large print versions of the instructions, memos and paper tasks. As previously 
mentioned, difficulties with visual acuity are a problem for people with MS, 
however this issue may be encountered with other populations, or simply with 
people who do not have good eyesight.  
These problems could be overcome by creating an update for the JEF© 
software to reflect how we currently use technology in 2018, for example 
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using a “click and drag” function to move objects and a “double-tap” function 
to move the individual around in the virtual space. In addition, coding the 
software in such a way the objects cannot disappear if the participant makes a 
mistake. It may also be helpful to have a way to measure how well 
participants are able to use the interface before starting the assessment. 
Perhaps with a few practice tasks which simply require the participant to move 
objects and navigate around the environment. The actual assessment would 
begin once participants were able to achieve these tasks in an optimum 
number of mouse clicks. 
 
12.1.2 Personal Reflections 
Although this was a challenging undertaking, I found this topic to be 
incredibly thought-provoking and stimulating. I have long been interested in 
the use of technology as a method of research and clinical assessment of 
psychological phenomena or difficulties. My undergraduate research involved 
using a computer program to assess differences in perception of 3D objects 
and faces. My Master’s research project involved administering the 
computerised human adaptation of a mouse battery originally designed to 
investigate fear, in a population who reported having difficulties with anxiety. 
This project has been a fascinating opportunity to see how technology can be 
used in both a research and potentially clinical capacity. 
Aside from gathering data, I also provided teaching and training to two 
members of the research team in how to run and administer the JEF© as well 
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as the neuropsychological battery. I first taught the undergraduate student 
and upon reflection was struck by how quickly I had become familiar with the 
test materials, something that was developed both through this project but 
also my clinical placement.  
Whilst I thought that the administration of certain tasks was fairly 
straightforward, I had to be remined that this was not the case for people who 
had little experience of using neuropsychological tests. I was then more 
careful to explain things more thoroughly as needed. This experience 
encouraged me to reflect on the idea of becoming an “unconsciously 
competent” practitioner, both as a researcher and a clinician, and the amount 
of learning I have done over these two and half years of training. Overall, I 
enjoyed working as part of a team with the data collections assistants and 
were I to do this study again would definitely consider including more 
assistants. 
One of the difficulties I encountered with testing, was trying to balance 
the need to build rapport for administering the tests and questionnaires with 
the need to move the patient quickly and efficiently through the test battery. 
Participants often wanted to clarify their responses on questionnaires or tell 
anecdotes related to their experiences of employment. Whilst on the one 
hand, I hoped that engaging in some of these conversations would serve to 
build rapport, facilitate engagement and convey to the individual that their 
participation was valued, I was also acutely aware that this might affect 
punctuality, making me late in seeing the next participant. 
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Whilst this something that I occasionally struggle with in clinical practice, 
it felt more marked and difficult to manage in my role as a researcher. In my 
clinical practice, clients would have been encouraged to adhere to the task 
and reassured that there would be an opportunity to share this information at 
a later date. However, I was aware that there was no other opportunity for this 
in this study and “cutting off” participants who were volunteering their time felt 
uncomfortable and invalidating of their experience and effort.  
As I tested more participants, I learnt from this experience and as part of 
the introduction would inform them that there was a lot to get through and that 
there may be occasions when I would need to move through subtests quickly 
in the interest of time. This seemed to be received well by the participants. 
During this project I attended a pop-up event in London organised by 
Shift.MS, an online charity who had agreed to help with recruitment. The 
event, held in Shoreditch, was very different to what I expected and was an 
eye-opening experience into the variety of charity events available to people 
with MS. The event clearly catered to a young, urban demographic of people 
with MS and the positive response and turn out showed me the importance of 
having a variety of charities and organisation which could cater for the 
different sub-groups of people with MS. 
The event included the premier of a short video called “The Commute”. 
This video followed three people with MS on their routes to work in various 
parts of the country. It was also a great experience to hear some real-life, 
qualitative accounts of the difficulties people with MS experience with regards 
to employment, as well as why they felt it was important to remain employed 
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some of which I had not considered. For example, one man spoke about how 
he hoped remaining employed would be a symbol of resilience in the face of 
adversity to his children. 
I used the event as an opportunity to reflect on my own thoughts and 
beliefs around employment and whether it was something I take for granted. 
This thesis and the degree in general have been challenging experiences, 
and at times it has been hard to find pleasure in it. Nevertheless, being 
amongst people who felt uncertain about their own careers and employment 
future made me realise how unhappy I would feel if I felt forced or unable to 
continue working and allowed me to empathise with their experience. 
Attending this event reminded me that neuropsychological data is only 
one part of formulating why a person with MS may end up leaving 
employment, of the importance of listening to the person and their narrative 
and considering the impact of other difficulties such as mental health.  
The reasons for remaining in employment presented in the video also 
made me consider the variety of reasons why someone with MS may choose 
to leave work. During the development of the project, service users were 
asked to provide their feedback about its design. One service user 
acknowledged that employment was important for some people, but also 
expressed his concern that this research, and similar studies, could be used 
to coerce people with MS into remaining employed. These experiences 
highlighted the need for a person-centred approach when working clinically, 
and that perhaps employment is used as a clinical indicator only if the client 
considers it to be an important value. 
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12.2 Dissemination 
A presentation of the research has already been delivered to Trainee 
Clinical Psychologists at Royal Holloway in May 2018. 
It is hoped a shortened version of the systematic review will be published 
in a peer reviewed journal. At this point it is anticipated that the paper will be 
submitted to the Journal of Multiple Sclerosis and Related Disorders 
(MSARD). This journal was chosen as it is an international journal which aims 
to publish a variety of articles including reviews, in order to teach and 
enhance the practice of clinicians, including psychologists, who are involved 
in the care of people with MS. The journal also provides summaries of key 
articles in a way that is accessible to a lay audience and had an impact factor 
of 2.35 in 2016. If it the review is not accepted by this journal, then an 
alternative publication with a similar audience and impact factor will be 
approached.   
It is anticipated that the empirical report will be published in 
Neuropsychological Rehabilitation. This is the same journal which published a 
paper on the JEF© with participants with acquired brain injury and focal frontal 
lobe lesions (Denmark et al., 2017; Jansari et al., 2014). The journal had an 
impact factor of 2.80 in 2016 and aims to publish material on experimental 
and clinical research related to neurorehabilitation and neuropsychological 
assessment. Previous papers published on neuropsychological research in 
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this journal include studies regarding the development of the BADS (Norris & 
Tate, 2000; Wilson et al., 1998). Similarly, if the report is not accepted an 
alternative journal with a similar readership and impact factor will be 
approached. 
A brief summary of the empirical article will also be sent to the MS 
Therapy Centres and MS charity websites which provided support with 
recruitment. These organisations would be encouraged to publish these 
reports in a newsletter which could be circulated to their members.  
Several MS Therapy Centre staff members pointed out that that their 
service users found it disheartening when they took part in research but did 
not hear anything about the results or see how it impacted their care or the 
understanding of their difficulties.  
Hearing feedback of results seems to be important for people with MS - 
in fact all participants with MS indicated on their consent form that they would 
like to have a summary of the results sent to them once available. Participants 
from the MS group will therefore receive a one-page summary of the results 
which will have more references to specifics of the program as they will be 
more familiar with it.  
A longer article, which will aim to encourage discussion around this 
topic, will be co-written with a service user with MS and published on an 
appropriate charity website such as Shift.MS. Collaborating with a service 
user will ensure that information that service users consider relevant is shared 
and that it is written in an accessible format for a lay audience. Shift.MS 
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currently have a plan to carry out and disseminate research on employment in 
MS over the next 18 months. It is possible that the empirical research 
undertaken as part of this thesis would complement the existing research they 
have and provide additional information about the role of executive function 
and cognitive impairment more generally in employment difficulties. 
 
12.3 Impact 
As a result of the plan for dissemination descried above, it is hoped that 
this thesis will lead to further research and development of ecologically valid 
tools for the assessment of cognition across a variety of populations, and that 
these tools will be available for use in clinical practice. The empirical study 
has demonstrated that ecologically valid tests are able to detect difficulties 
which may not be found when using less ecologically valid measures of 
executive function, such as the Stroop Test (Chaytor, Schmitter-Edgecombe, 
& Burr, 2006). This outcome may encourage clinicians to use ecologically 
valid tests as part of their assessment batteries more routinely.  
This is the ninth study to use the JEF© in research and it is hoped the 
outcome of this study will contribute to its development and use as a 
neuropsychological assessment tool within clinical populations. Suggestions 
have been made regarding how to improve the interface and these could be 
shared with its creator to see if this is the first time these problems have been 
encountered, whether suggested changes could feasibly be implemented or 
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whether alternative solutions could be found. The positive results of this study 
also provide further support for the use of virtual reality to assess cognition.  
Approximately 50% of PwMS with low levels of physical disability are 
unemployed across Europe, resulting in significant individual and societal 
costs (Kobelt et al., 2017). It is a subject that therefore warrants further 
investigation in order to reduce the negative impact caused. To the best of my 
knowledge, the systematic review is the first which investigates the link 
specifically between objective cognitive ability and employment outcomes in 
MS. Hopefully the outcome of the review will provide information which new 
researchers could use as a base for understanding and exploring the 
literature and be an informative synthesis of information for more experienced 
researchers and clinicians working with PwMS. 
Furthermore, it is hoped that additional evidence of the relationship 
between cognition and work outcomes for people with MS will encourage 
policy makers to consider what steps they could take to ensure that PwMS 
can remain in employment for as long as they choose. This may include 
creating or strengthening initiatives that provide businesses with the means to 
acquire or implement accommodations which would help people with MS stay 
in work.  
Ensuring that this research is appropriately disseminated to service 
users means that the knowledge will be held by people who are already 
campaigning for changes to policy. This will hopefully be achieved not only 
through collaborating with service users to write an article specifically for 
PwMS, but also through disseminating this information in an accessible 
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manner to service users who may not have considered the potential impact of 
cognitive changes on their employment. It is hoped that this will lead to 
increased awareness of the challenges faced by people with MS within the 
general population, as publication on websites with social media links may 
reach people who know very little about the disease. Increased awareness 
may result in more support for this group to gain the tools it needs to reduce 
the impact of cognition on employment.   
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14 Appendices 
14.1 Appendix I: Questionnaires 
14.1.1 Multiple Sclerosis Work Difficulties 
Questionnaire (MSWDQ) 
Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ) 
Instructions 
People with MS often experience difficulties in the workplace that are either directly or 
indirectly related to their symptoms. The following questions describe several difficult or 
problem situations that a person with MS may encounter at work. Please circle the 
appropriate response (0, 1, 2,…) based on your everyday experience over the last four weeks 
in your current or most recent job. Please answer every question, and if you are not sure 
which answer to select, please choose the one that comes closest to describing you. 
During the past four weeks whilst working in your current or most recent job, please indicate 
how frequently you experienced the following as a result of your MS. 
 
 Never Rarely Sometimes Often Almost 
Always 
1. I felt that I had to work because 
of my financial position 
1 2 3 4 5 
2. I hesitated to proceed on an 
everyday task 
1 2 3 4 5 
3. I experienced a lack of 
coordination with my movements 
1 2 3 4 5 
4. I felt social isolated 1 2 3 4 5 
5. I thought that my employer was 
not very understanding of my 
needs 
1 2 3 4 5 
6. I forgot about a deadline I had to 
meet 
1 2 3 4 5 
7. I felt I was not appropriately 
recognised for my work 
1 2 3 4 5 
8. I found it difficult to learn 
something new 
1 2 3 4 5 
9. I found it difficult to use my hands 1 2 3 4 5 
10. I had problems with walking 1 2 3 4 5 
11. I thought that my manager or 
work colleagues were not 
1 2 3 4 5 
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supportive of me 
12. I felt that I was not valued by my 
work colleagues 
1 2 3 4 5 
13. I feared that I might be too tired 
to deal effectively with others 
1 2 3 4 5 
14. I felt that disturbances in my 
bowel or bladder function 
distracted me from doing a task 
1 2 3 4 5 
15. I experienced difficulties getting 
to and from my workplace 
1 2 3 4 5 
16. I had trouble remembering 
something I recently read 
1 2 3 4 5 
17. I thought that work was 
interfering with my home 
responsibilities 
1 2 3 4 5 
18. I needed to be reminded to do a 
task at a particular time 
1 2 3 4 5 
19. I forgot to do a task that someone 
asked me to do 
1 2 3 4 5 
20. I felt that I could not perform to 
the level that was expected of me 
1 2 3 4 5 
21. I found it difficult to tolerate the 
temperature at work 
1 2 3 4 5 
22. I feared that I was going to let my 
work colleagues down 
1 2 3 4 5 
23. I found accessing my office or 
worksite difficult 
1 2 3 4 5 
24. I feared that I would break wind 
in front of other people 
1 2 3 4 5 
25. I struggled to remember a recent 
conversation 
1 2 3 4 5 
26. I felt embarrassed by my 
bladder/bowel problems 
1 2 3 4 5 
27. I experienced pain whilst 
undertaking a task 
1 2 3 4 5 
28. I feared that I would not be able 
to support myself if I could no 
longer work 
1 2 3 4 5 
29. I felt too tired to undertake a task 1 2 3 4 5 
30. I became sleepy whilst trying to 
undertake a task 
1 2 3 4 5 
31. I forgot to attend a meeting or 
appointment 
1 2 3 4 5 
32.  I felt that the amount of pay I 
received was not adequate for my 
needs 
1 2 3 4 5 
33. I found it difficult to maintain my 
balance 
1 2 3 4 5 
34. I had to read something more 1 2 3 4 5 
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than once to understand it 
35. I had trouble concentrating on a 
task 
1 2 3 4 5 
36. I felt I did not have easy access to 
facilities (e.g. bathroom, kitchen, 
elevators) 
1 2 3 4 5 
37. I had difficulty with 
communicating my thoughts to 
co-workers 
1 2 3 4 5 
38. I felt that it was more difficult to 
balance work and home duties 
1 2 3 4 5 
39. I found it hard to think clearly 1 2 3 4 5 
40. I found it difficult to write or type 1 2 3 4 5 
41. I found it hard to do my work 
because my muscles or joints 
were hurting 
1 2 3 4 5 
42. I found it difficult to stand for 
long periods of time 
1 2 3 4 5 
43. I felt unable to manage stairs 1 2 3 4 5 
44. I did not have adequate access to 
devices to assist me (e.g. electric 
wheelchair 
1 2 3 4 5 
45. I found it difficult to interact with 
people 
1 2 3 4 5 
46. I thought that I was being 
discriminated against 
1 2 3 4 5 
47. I feared that I would be 
incontinent 
1 2 3 4 5 
48. I found it difficult to reduce my 
work hours because my pay 
would also be reduced 
1 2 3 4 5 
49. I forgot what task I had to do 1 2 3 4 5 
50. I felt that work was becoming 
harder due to responsibilities at 
home 
1 2 3 4 5 
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14.1.2 Multiple Sclerosis Questionnaire for the 
Evaluation of Job Difficulties (MSQ-Job) 
The Multiple Sclerosis Questionnaire for the evaluation of Job 
Difficulties (MSQ-Job) 
The following statements are on your health, on your workplace and on the 
context in which you carry out your working activities. For each item, please 
think to the degree to which your health or the context in which you work had 
an impact over your difficulties in carrying out your working activities.  
Each item has to be rated on a 1-5 scale reflecting how much of an impact did 
it have on work difficulties: No – Mild – Moderate – Severe – Complete  
 
1. Tactile perception and fine 
movement 
How much of an impact did the following 
issues had on work difficulties? 
No Mild Moderat
e 
Severe Complete 
1.1) Difficulties in perceiving tactile stimuli      
1.2) Difficulties in using computer      
1.3) Difficulties in fine hand movements      
1.4) Physical impairments affecting 
hands/arms (e.g. poor sensitivity, lack of 
strength…) 
     
1.5) Sensitivity to warmth/cold (e.g. loss of 
sensitivity, effect of temperature on 
sensitivity) 
     
1.6) Physical impairments affecting 
legs/feet (e.g. poor sensitivity, lack of 
strength…) 
     
2. Fatigue-related mental functions and 
symptoms 
How much of an impact did the following 
issues had on work difficulties? 
No Mild Moderat
e 
Severe Complete 
2.1) Difficulties in understanding      
2.2) Difficulties with memory      
2.3) Difficulties in learning new tasks      
2.4) Difficulties in pronouncing specific 
words 
     
2.5) Visual disturbances      
2.6) Feeling sad, blue or depressed      
2.7) Feeling anxious or overly worried      
2.8) Difficulties with sleeping      
2.9) Feeling of being not productive or      
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efficient 
3. Movement and fatigue-related body 
functions  
How much of an impact did the following 
issues had on work difficulties? 
No Mild Moderat
e 
Severe Complete 
3.1) Movement difficulties (e.g. moving 
around, walking) 
     
3.2) Problems with balance or dizziness      
3.3) Difficulties in standing for a long 
period 
     
3.4) Difficulties related to getting easily 
tired 
     
3.5) Difficulties with movement 
coordination 
     
3.6) Bowel problems      
3.7) Difficulties related to fatigue      
4. Psychological and relational aspects 
How much of an impact did the following 
issues had on work difficulties? 
No Mild Moderat
e 
Severe Complete 
4.1) Lack of motivation      
4.2) Sense of isolation      
4.3) Poor self-confidence      
4.4) Difficulties in relating with others      
4.5) Poor confidence in one’s own working 
future 
     
4.6) Sense of inadequacy      
5. Time and organization flexibility in 
the workplace 
How much of an impact did the following 
issues had on work difficulties? 
No Mild Moderat
e 
Severe Complete 
5.1) Poor or no flexibility in working hours      
5.2) Poor opportunities to get part-time 
working hours 
     
5.3) Having to work on shifts or work 
overtime frequently 
     
5.4) Poor opportunities to take breaks 
during working hour 
     
5.5) Poor opportunities to obtain paid 
leaves 
     
5.6) Poor opportunities to make changes 
(of task, role or working hours) 
     
5.7) Poor opportunities to work at home/do 
teleworking 
     
6. Company’s attitudes and policies 
How much of an impact did the following 
issues had on work difficulties? 
No Mild Moderat
e 
Severe Complete 
6.1) Lack of information on disability and 
work rules, and on the rights of workers 
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with disabilities in the workplace 
6.2) Lack of knowledge on national 
disability laws 
     
6.3) Poor knowledge on the disease and 
its symptoms in the workplace 
     
6.4) Poor opportunities to obtain 
psychological support 
     
6.5) Lack of good relationships with the 
employer or lack of comprehension and 
appreciation 
     
6.6) Poor career growth opportunities       
6.7) Uncertain or inadequate financial 
and/or social security perspectives 
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14.1.3 COPE Inventory 
COPE Inventory 
We are interested in how people respond when they confront difficult or stressful events in 
their lives. There are lots of ways to try to deal with stress.  This questionnaire asks you to 
indicate what you generally do and feel, when you experience stressful events.  Obviously, 
different events bring out somewhat different responses, but think about what you usually do 
when you are under a lot of stress. 
Then respond to each of the following items by writing the number that corresponds with 
your answer next to the statement.  Please try to respond to each item separately in your mind 
from each other item.  Choose your answers thoughtfully, and make your answers as true 
FOR YOU as you can.  Please answer every item.  There are no "right" or "wrong" answers, 
so choose the most accurate answer for YOU--not what you think "most people" would say or 
do.  Indicate what YOU usually do when YOU experience a stressful event. 
       1 = I usually don't do this at all  
       2 = I usually do this a little bit  
       3 = I usually do this a medium amount  
       4 = I usually do this a lot 
 
1.  I try to grow as a person as a result of the experience.  
2.  I turn to work or other substitute activities to take my mind off things.  
3.  I get upset and let my emotions out.  
4.  I try to get advice from someone about what to do.  
5.  I concentrate my efforts on doing something about it.  
6.  I say to myself "this isn't real."  
7.  I put my trust in God.  
8.  I laugh about the situation.  
9.  I admit to myself that I can't deal with it, and quit trying.  
10.  I restrain myself from doing anything too quickly. 
11.  I discuss my feelings with someone.  
12.  I use alcohol or drugs to make myself feel better.  
13.  I get used to the idea that it happened.  
14.  I talk to someone to find out more about the situation.  
15.  I keep myself from getting distracted by other thoughts or activities.  
16.  I daydream about things other than this.  
17.  I get upset, and am really aware of it.  
18.  I seek God's help.  
19.  I make a plan of action.  
20.  I make jokes about it. 
21.  I accept that this has happened and that it can't be changed.  
22.  I hold off doing anything about it until the situation permits.  
23.  I try to get emotional support from friends or relatives.  
24.  I just give up trying to reach my goal.  
25.  I take additional action to try to get rid of the problem.  
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26.  I try to lose myself for a while by drinking alcohol or taking drugs.  
27.  I refuse to believe that it has happened.  
28.  I let my feelings out.  
29.  I try to see it in a different light, to make it seem more positive.  
30.  I talk to someone who could do something concrete about the problem. 
31.  I sleep more than usual.  
32.  I try to come up with a strategy about what to do.  
33.  I focus on dealing with this problem, and if necessary let other things slide a little.  
34.  I get sympathy and understanding from someone.  
35.  I drink alcohol or take drugs, in order to think about it less.  
36.  I kid around about it.  
37.  I give up the attempt to get what I want.  
38.  I look for something good in what is happening.  
39.  I think about how I might best handle the problem.  
40.  I pretend that it hasn't really happened. 
41.  I make sure not to make matters worse by acting too soon.  
42.  I try hard to prevent other things from interfering with my efforts at dealing with this.  
43.  I go to movies or watch TV, to think about it less.  
44.  I accept the reality of the fact that it happened.  
45.  I ask people who have had similar experiences what they did.  
46.  I feel a lot of emotional distress and I find myself expressing those feelings a lot.  
47.  I take direct action to get around the problem.  
48.  I try to find comfort in my religion.  
49.  I force myself to wait for the right time to do something.  
50.  I make fun of the situation. 
51.  I reduce the amount of effort I'm putting into solving the problem.  
52.  I talk to someone about how I feel.  
53.  I use alcohol or drugs to help me get through it.  
54.  I learn to live with it.  
55.  I put aside other activities in order to concentrate on this.  
56.  I think hard about what steps to take.  
57.  I act as though it hasn't even happened.  
58.  I do what has to be done, one step at a time.  
59.  I learn something from the experience.  
60.  I pray more than usual. 
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14.1.4 Hospital Anxiety and Depression Scale (HADS) 
Hospital Anxiety and Depression Scale (HADS) 
 
Instructions: Read each item and circle the reply which comes closest to how you 
have been feeling in the past week. Don’t take too long over your replies: your 
immediate reaction is best. 
 
 
I feel tense or ‘wound up’:  A   I feel as if I am slowed down:  D  
Most of the time  3   Nearly all of the time  3  
A lot of the time  2   Very often  2  
Time to time, occasionally  1   Sometimes  1  
Not at all  0   Not at all  0  
     
I still enjoy the things I used to 
enjoy:  
D    I get a sort of frightened feeling 
like ‘butterflies in the stomach’:  
A  
Definitely as much  0    Not at all  0  
Not quite so much  1    Occasionally  1  
Only a little  2    Quite often  2  
Not at all  3    Very often  3  
     
I get a sort of frightened feeling 
like something awful is about to 
happen:  
A   I have lost interest in my 
appearance:  
D  
Very definitely and quite badly  3   Definitely  3  
Yes, but not too badly  2   I don’t take as much care as I should  2  
A little, but it doesn’t worry me  1   I may not take quite as much care  1  
Not at all  0   I take just as much care as ever  0  
     
I can laugh and see the funny 
side of things:  
D    I feel restless as if I have to be on 
the move:  
A  
As much as I always could  0    Very much indeed  3  
Not quite so much now  1    Quite a lot  2  
Definitely not so much now  2    Not very much  1  
Not at all  3    Not at all  0  
     
Worrying thoughts go through 
my mind:  
A   I look forward with enjoyment to 
things:  
D  
A great deal of the time  3   A much as I ever did  0  
A lot of the time  2   Rather less than I used to  1  
From time to time but not too 
often  
1   Definitely less than I used to  2  
Only occasionally  0   Hardly at all  3  
     
I feel cheerful:  D    I get sudden feelings of panic:  A  
Not at all  3    Very often indeed  3  
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Not often  2    Quite often  2  
Sometimes  1    Not very often  1  
Most of the time  0    Not at all  0  
     
I can sit at ease and feel relaxed:  A   I can enjoy a good book or radio or 
TV programme:  
D  
Definitely  0   Often  0  
Usually  1   Sometimes  1  
Not often  2   Not often  2  
Not at all  3   Very seldom  3  
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14.1.5 Fatigue Severity Scale (FSS) 
Fatigue Severity Scale 
 
Instructions: Circle the number that best represents your response to each 
question. 
Scoring Range: 1= strongly disagree with the statement. 7= strongly agree 
with the statement 
 
During the past week, I have found that: Disagree <----------------------> Agree 
1. My motivation is lower when I am 
fatigued. 
1 2 3 4 5 6 7 
2. Exercise brings on my fatigue. 1 2 3 4 5 6 7 
3. I am easily fatigued. 1 2 3 4 5 6 7 
4. Fatigue interferes with my physical 
functioning. 
1 2 3 4 5 6 7 
5. Fatigue causes frequent problems for 
me. 
1 2 3 4 5 6 7 
6. My fatigue prevents sustained physical 
functioning. 
1 2 3 4 5 6 7 
7. Fatigue interferes with carrying out 
certain duties and responsibilities. 
1 2 3 4 5 6 7 
8. Fatigue is among my three most 
disabling symptoms. 
1 2 3 4 5 6 7 
9. Fatigue interferes with my work, family, 
or social life. 
1 2 3 4 5 6 7 
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14.2 Appendix II 
14.2.1 Graph of JEF© Results 
 
 
Figure 4: JEF© Performance as a Function of Group (error bars represent one standard error) 
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14.3 Appendix III: Information Sheets and Consent Forms 
14.3.1 Information Sheet for People with Multiple 
Sclerosis 
 
 
 
 
 
 
 
 
 
Participant Information Sheet 
 
Study Title: Investigation of Executive Function in Multiple Sclerosis and 
employment performance. 
 
We would like to invite you to take part in a research study. The study aims to assess 
higher brain functions, collectively known as “executive function”, using a new, 
computer-based test known as the Jansari assessment of Executive Function (JEF©) 
in the Multiple Sclerosis (MS) population. We are interested in seeing how this new 
test compares to other traditional, pen-and-paper tests of executive function and if the 
JEF© is more reflective of experiences in the workplace. 
 
Before you decide whether or not to take part it is important that you understand why 
the research is being done and what it would involve for you. Please take time to read 
the following information carefully and discuss it with relatives or friends, or your 
GP. 
 
What is the purpose of the study? 
 
Multiple Sclerosis is a long term neurological disease which affects approximately 2.3 
million people worldwide. A significant number of people with MS are unemployed 
because of the disease despite only having mild to moderate physical disabilities. It is 
likely that this is due to invisible symptoms of MS, such as problems with cognition 
(thinking, memory and other mental skills). As many people are diagnosed when they 
are of working age, unemployment can have a negative impact on quality of life.  
 
Difficulties with memory and concentration are frequent for people with Multiple 
Sclerosis. They can be one of the earlier symptoms noticed and have been linked to 
unemployment. “Executive function” is an umbrella term for a set of complex mental 
skills needed to successfully plan and complete a chosen task. These abilities, which 
include planning, organisation and memory, are often needed in the workplace as well 
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as in daily life. Impairment in this area can therefore have significant consequences 
for individuals including their ability to use effective coping strategies.  
 
A thorough assessment of an individual’s cognitive problems can inform management 
plans. However, some traditional, pen-and-paper neuropsychological tests do not 
reflect real world tasks and can miss cognitive impairments which can affect everyday 
functioning. 
 
The Jansari assessment of Executive Function (JEF©) is a new, computer-based test 
which takes place in a virtual office environment. It has been shown to detect 
executive function difficulties in other patient groups which have gone undetected by 
traditional, pen-and-paper neuropsychological tests. This test has yet to be used in the 
MS population. As the JEF assesses skills which are more closely related to real life, 
it may be a better way of assessing and monitoring these difficulties in the MS 
population and provide further information about how these difficulties affect 
employment. This study would therefore investigate whether the JEF© is sensitive to 
difficulties in this group and see how it compares to traditional, pen-and-paper 
neuropsychological tests.  
 
Who is organising and conducting the research? 
The research is being supervised by Professor Dawn Langdon PhD, a Clinical 
Neuropsychologist and Professor in Neuropsychology at Royal Holloway, University 
of London. The study is being carried out by Laura Clemens BSc MSc, who is a 
psychology graduate and Trainee Clinical Psychologist at Royal Holloway, University 
of London.  
 
Why have I been invited? 
You have been given this information sheet as you have indicated that you are 
interested in taking part in this study and may be a suitable participant. 
 
Do I have to take part? 
No. It is up to you to decide whether or not to take part.  
 
What will happen to me if I take part? 
You will speak to the researcher Laura Clemens, on the telephone. She will describe 
the study in more detail, go through this information sheet and check whether you 
want to take part or not. If you would like to take part she will ask you a few 
questions to confirm your eligibility. You would be free to withdraw from the study at 
any time, without giving a reason.  
 
If you agree and are eligible to take part, a testing time and location will be agreed 
between you and the researcher. You will be asked to sign a consent form which 
states that you have read the information sheet, been given time to ask questions, 
understand that you are free to withdraw at any time and that you agree to take part.  
 
The study will involve you completing a number of neuropsychological tests which 
should take no more than 1.5 hours to complete. You will then be asked to complete 
some questionnaires related to: employment performance, coping strategies, mood 
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and fatigue. We anticipate that the questionnaires will take no more than 30 minutes 
to complete. 
 
There are no right or wrong answers, and you are free to decline to answer any 
question you do not feel happy to answer.  
 
Expenses and payments 
We regret that we are unable to cover expenses or offer payment for participation in 
this study.  
 
What are the possible disadvantages or risks of taking part? 
We do not anticipate that there will be any disadvantages to taking part, except for the 
time commitment needed to complete the study. We anticipate that the 
neuropsychological tests will not take longer than 1.5 hours and it is unlikely, but 
possible that you may feel fatigued during testing. We will monitor you closely for 
signs of fatigue and you will be able to have short breaks at appropriate points during 
testing if necessary.  
 
What are the possible benefits of taking part? 
We hope that this research will contribute to the validation of the JEF© as a measure 
that can produce results which are representative of real life experiences and 
difficulties and in turn improve disease monitoring and management. We will not be 
able to give you feedback on your performance as the testing battery does not 
constitute a full clinical assessment and therefore would not give us a fully accurate 
representation of your strengths and weaknesses.   
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice, and all information about you will be 
handled in confidence. 
 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw at any point, without giving a reason. You have the right to 
withdraw consent after it has been given, and to ask that your own data be destroyed.  
 
What if there is a problem? 
If you have any queries or concerns about the study please contact the researcher, 
Laura Clemens, on 07707 207992 or Laura.Clemens.2006@live.rhul.ac.uk in the first 
instance, or Prof Dawn Langdon, Clinical Neuropsychologist on 
D.Langdon@rhul.ac.uk. Any complaints about the way you have been dealt with 
during the study or any possible harm you might have suffered will be addressed.  
 
If you remain unhappy and wish to complain formally about any aspect of the way 
you have been approached or treated during the course of this study, you may contact 
Prof Dawn Langdon on the details above. 
 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence then you may have grounds for legal action 
for compensation, but you have to pay your own legal costs. Royal Holloway, 
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University of London, is providing negligent and non-negligent indemnity cover for 
this research.  
 
Will my taking part in this study be kept confidential? 
Yes. All data collected during the course of the study will be held according to the 
Data Protection Act (1998). All data collected will be anonymised and given a unique 
identification number. This means that only the researcher will know whose data 
belongs to whom. Your name will not be disclosed to anyone else, nor will you be 
identified in any report or publication.  
 
All anonymised paper data will be stored securely in a locked filing cabinet that only 
Laura Clemens or Prof Dawn Langdon will have access to. All electronic data will be 
stored on a secure encrypted electronic storage device. On completion of the study, a 
copy of anonymised results from the JEF© will be given to Prof Ashok Jansari, the 
creator of the JEF©, and added to the existing dataset for use in future research. 
Signed consent forms will be stored securely at Royal Holloway University, and 
destroyed after two years.  
 
What will happen to the results of the research study? 
The results of the study will be written up as part of a Doctorate in Clinical 
Psychology. The results may also be published in a journal, presented at a conference 
or shared through an appropriate forum for people with MS. All published results will 
be anonymised and you will not be identified in any way. If you indicate your interest, 
we will also supply a summary of the findings.  
 
Who has reviewed the study? 
This study has been reviewed and given approval by the research subcommittee and 
ethics committee at Royal Holloway, University of London.  
 
 
What do I do next if I wish to take part? 
• Please contact the researcher, Laura Clemens, Trainee Clinical Psychologist 
either by emailing her on Laura.Clemens.2006@live.rhul.ac.uk or leaving a 
telephone message on 07707 207992 If leaving a message please make sure to 
say that you wish to speak with Laura Clemens and leave a contact number 
and best day/time to contact you. 
• The researcher will then contact you by telephone and give you the chance to 
ask questions before you decide whether to participate. Please ask if there is 
anything that is not clear, or if you would like more information. 
 
 
Thank you for considering taking part and/or taking time to read this sheet.  
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14.3.2 Consent Form for People with Multiple Sclerosis 
 
 
 
 
 
 
 
 
CONSENT FORM FOR PEOPLE WITH MS 
 
 
Study Title: Investigation of Executive Function in Multiple Sclerosis and 
employment performance. 
 
 
Please 
initial 
 
1. I confirm that I have read and understand the information sheet   
 
 for the above study. I have had the opportunity to consider the 
 information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
 
 at any time, without giving any reason.   
 
3. I understand that information concerning my task performance,   
 
 and questionnaires will be used by the researchers solely for the purpose 
 of this study and will be stored coded and confidentially.  
  
4. I understand that unidentifiable information about my results on the  
 
computer based task (the JEF) will be given to its creator, Professor  
Ashok Jansari, to be used in further research. 
 
5. I would like to receive a brief summary of the outcome of this study. I   
 
understand that this summary will not detail my individual results.   
 
6. I agree to take part in the above study      
 
 
________________________  ____________________ ________________ 
Name of Participant   Signature   Date 
 
 
________________________  ____________________ ________________ 
Name of Researcher   Signature   Date  
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14.3.3 Information Sheet for Healthy Control 
Participants 
 
 
 
 
 
 
 
Healthy Control Participant Information Sheet 
 
Study Title: Investigation of Executive Function in Multiple Sclerosis and 
employment performance. 
 
We would like to invite you to take part in a research study. The study aims to assess 
higher brain functions, collectively known as “executive function”, using a new, 
computer-based test known as the Jansari assessment of Executive Function (JEF©) 
in the Multiple Sclerosis (MS) population. We also need to recruit and assess healthy 
volunteers to compare their results to those of people with MS. We are interested in 
seeing how this new test compares to other traditional, pen-and-paper tests of 
executive function and if the JEF© is more reflective of experiences in the workplace. 
 
Before you decide whether or not to take part it is important that you understand why 
the research is being done and what it would involve for you. Please take time to read 
the following information carefully and discuss it with relatives or friends if you wish.  
 
What is the purpose of the study? 
 
Multiple Sclerosis is a long term neurological disease which affects approximately 2.3 
million people worldwide. A significant number of people with MS are unemployed 
because of the disease despite only having mild to moderate physical disabilities. It is 
likely that this is due to invisible symptoms of MS, such as problems with cognition 
(thinking, memory and other mental skills). As many people are diagnosed when they 
are of working age, unemployment can have a negative impact on quality of life.  
 
Varying degrees of impairment in cognitive abilities (thinking) are relatively common 
within this population. They can be one of the earlier symptoms noticed and have 
been linked to unemployment. “Executive function” is an umbrella term for a set of 
complex mental skills needed to successfully plan and complete a chosen task. These 
abilities, which include planning, organisation and memory, are often needed in the 
workplace as well as in daily life. Impairment in this area can therefore have 
significant consequences for individuals including their ability to use effective coping 
strategies.  
 
A thorough assessment of an individual’s cognitive problems can inform management 
plans. However, some traditional, pen-and-paper neuropsychological tests do not 
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reflect real world tasks and can miss cognitive impairments which can affect everyday 
functioning. 
 
The Jansari assessment of Executive Function (JEF©) is a new, computer-based test 
which takes place in a virtual office environment. It has been shown to detect 
executive function difficulties in other patient groups which have gone undetected by 
traditional, pen-and-paper neuropsychological tests. This test has yet to be used in the 
MS population. As the JEF assesses skills which are more closely related to real life, 
it may be a better way of assessing and monitoring these difficulties in the MS 
population and provide further information about how these difficulties affect 
employment. This study would therefore investigate whether the JEF© is sensitive to 
deficits in this group and see how it compares to traditional, pen-and-paper 
neuropsychological tests. We are collecting our own healthy control data as there is 
no existing normed control data for the JEF© 
 
Who is organising and conducting the research? 
The research is being supervised by Professor Dawn Langdon PhD, a Clinical 
Neuropsychologist and Professor in Neuropsychology at Royal Holloway, University 
of London. The study is being carried out by Laura Clemens BSc MSc, who is a 
psychology graduate and Trainee Clinical Psychologist at Royal Holloway, University 
of London.  
 
Why have I been invited? 
We need to recruit a healthy control group to compare their results to those of people 
with MS. You have been given this information sheet as you may be suitable for the 
study and may be interested in taking part. 
 
Do I have to take part? 
No. It is up to you to decide whether or not to take part. 
 
What will happen to me if I take part? 
You will speak to the researcher Laura Clemens, on the telephone. She will describe 
the study in more detail, go through this information sheet and check whether you 
want to take part or not. If you would like to take part she will ask you a few 
questions to confirm your eligibility. You would be free to withdraw from the study at 
any time, without giving a reason.  
 
If you agree and are eligible to take part, a testing time and location will be agreed 
between you and the researcher. You will be asked to sign a consent form which 
states that you have read the information sheet, been given time to ask questions, 
understand that you are free to withdraw at any time and that you agree to take part.  
 
The study will involve you completing a number of neuropsychological tests which 
should take no more than 1.5 hours to complete. You will then be asked to complete 
some questionnaires related to: employment performance, coping strategies, mood 
and fatigue. We anticipate that the questionnaires will take no more than 30 minutes 
to complete. 
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There are no right or wrong answers, and you are free to decline to answer any 
question you do not feel happy to answer.  
 
Expenses and payments 
We regret that we are unable to cover expenses or offer payment for participation in 
this study.  
 
What are the possible disadvantages or risks of taking part? 
We do not anticipate that there will be any disadvantages to taking part, except for the 
time commitment needed to complete the study. We anticipate that the 
neuropsychological tests will not take longer than 1.5 hours and it is unlikely, but 
possible that you may feel fatigued during testing. We will monitor you closely for 
signs of fatigue and you will be able to have short breaks at appropriate points during 
testing if necessary.  
 
What are the possible benefits of taking part? 
We hope that this research will contribute to the validation of the JEF© as a measure 
that can produce results which are representative of real life experiences and 
difficulties and in turn improve disease monitoring and management. We will not be 
able to give you your test scores as the testing battery does not constitute a full 
clinical assessment and therefore would not give us a fully accurate representation of 
your strengths and weaknesses.   
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice, and all information about you will be 
handled in confidence. 
 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw at any point, without giving a reason. Refusal or withdrawal 
of consent will not affect any future care or treatment that you receive. You have the 
right to withdraw consent after it has been given, and to ask that your own data be 
destroyed.  
 
What if there is a problem? 
If you have any queries or concerns about the study please contact the researcher, 
Laura Clemens, on 07707 207992 or Laura.Clemens.2006@live.rhul.ac.uk in the first 
instance, or Prof Dawn Langdon, Clinical Neuropsychologist on 
D.Langdon@rhul.ac.uk. Any complaints about the way you have been dealt with 
during the study or any possible harm you might have suffered will be addressed.  
 
If you remain unhappy and wish to complain formally about any aspect of the way 
you have been approached or treated during the course of this study, you may contact 
Prof Dawn Langdon on the details above. 
 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence then you may have grounds for legal action 
for compensation, but you have to pay your own legal costs. Royal Holloway, 
University of London, is providing negligent and non-negligent indemnity cover for 
this research. The normal NHS complaints mechanisms will still be available to you.  
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Will my taking part in this study be kept confidential? 
Yes. All data collected during the course of the study will be held according to the 
Data Protection Act (1998). All data collected will be anonymised and given a unique 
identification number. This means that only the researcher will know whose data 
belongs to whom. Your name will not be disclosed to anyone else, nor will you be 
identified in any report or publication.  
 
All anonymised paper data will be stored securely in a locked filing cabinet that only 
Laura Clemens or Prof Dawn Langdon will have access to. All electronic data will be 
stored on a secure encrypted electronic storage device. On completion of the study, a 
copy of anonymised results from the JEF© will be given to Prof Ashok Jansari, the 
creator of the JEF©, and added to the existing dataset for use in future research. 
Signed consent forms will be stored securely at Royal Holloway University, and 
destroyed after two years.  
 
What will happen to the results of the research study? 
The results of the study will be written up as part of a Doctorate in Clinical 
Psychology. The results may also be published in a journal, presented at a conference 
or shared through an appropriate forum for people with MS. All published results will 
be anonymised and you will not be able to be identified in any way. If you indicate 
your interest, we will also offer you a summary of the findings. 
 
Who has reviewed the study? 
This study has been reviewed and given approval by the research subcommittee at 
Royal Holloway, University of London.  
All NHS research is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your interests.  
 
What do I do next if I wish to take part? 
• Please contact the researcher, Laura Clemens, Trainee Clinical Psychologist 
either by emailing her on Laura.Clemens.2006@live.rhul.ac.uk or leaving a 
telephone message on 07707 207992 If leaving a message please make sure to 
say that you wish to speak with Laura Clemens and leave a contact number 
and best day/time to contact you. 
• The researcher will then contact you by telephone and give you the chance to 
ask questions before you decide whether to participate. Please ask if there is 
anything that is not clear, or if you would like more information. 
 
 
Thank you for considering taking part and/or taking time to read this sheet.  
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14.3.4  Consent Form for Healthy Control Participants 
 
 
 
 
 
 
CONSENT FORM FOR HEALTHY VOLUNTEERS 
 
 
 
Study Title: Investigation of Executive Function in Multiple Sclerosis and 
employment performance. 
 
 
Please 
initial 
 
1. I confirm that I have read and understand the information sheet   
  
 for the above study. I have had the opportunity to consider the 
 information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
  
 at any time, without giving any reason.   
 
3. I understand that information concerning my task performance,   
  
 and questionnaires will be used by the researchers solely for the purpose 
 of this study and will be stored coded and confidentially.  
  
4. I understand that unidentifiable information about my results on the  
  
computer based task (the JEF©) will be given to its creator, Professor  
Ashok Jansari, to be used in further research. 
 
5. I would like to receive a brief summary of the outcome of this study. I   
  
understand that this summary will not detail my individual results.   
 
6.     I agree to take part in the above study      
  
________________________  ____________________ ________________ 
Name of Participant   Signature   Date 
 
________________________  ____________________ ________________ 
Name of Researcher   Signature   Date  
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14.4 Ethical Approval Documentation 
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